Clinical Trial Resource Center


Therapeutic Areas: Oncology | Hematology | Musculoskeletal

Leukemia Clinical Trials


A listing of Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama at Birmingham

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Birmingham : University of Alabama Comprehensive Cancer Center University of Alabama

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Mobile : USA Mitchell Cancer Institute

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Muscle Shoals : Northwest Alabama Cancer Center, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Tuscaloosa : DCH Health System

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Alaska

Anchorage : Alaska Clinical Research

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Arizona

Phoenix : US Oncology - Arizona Oncology Associates, PC - HAL - Phoenix

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Phoenix : Arizona Oncology Associates Dept. Of Onc.

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Scottsdale : US Oncology - Arizona Oncology Associates, PC - HAL - Scottsdal

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Scottsdale : Scottsdale Healthcare Research Institute

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale : Mayo Clinic Scottsdale-Phoenix

Patients are needed to participate in a clinical research study of EPZ-5676

Tucson : US Oncology - Arizona Oncology Associates - Rudasill

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tucson : US Oncology - Arizona Oncology Associates - Carondelet

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tucson : Site Reference ID/Investigator# 96748

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Tucson : University of Arizona Cancer Center Updated

A Phase 3 clinical study for patients with AML

Tucson : Arizona Oncology Associates

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Arkansas

Fayetteville :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Fort Smith : St. Edward Mercy Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hot Springs : Genesis Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hot Springs : Genesis Cancer Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Jonesboro : Clopton Clinic of Jonesboro Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Jonesboro : NEA Baptist Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Little Rock : US Oncology - Hematology Oncology Services of Arkansas

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Little Rock : Little Rock Hematology Oncology Associates, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

California

Anaheim : Pacific Cancer Medical Center, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Anaheim : Pacific Cancer Medical Center Inc.

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Berkeley : Alta Bates Summit Comprehensive Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Burbank : East Valley Hematology and Oncology Medical Group

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Campbell : Southbay Oncology Hematology Partners

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Concord : Bay Area Cancer Research Group

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Corona : Compassionate Cancer Care Medical Group (Corona)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Duarte : Site Reference ID/Investigator# 129718

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Duarte : Site Reference ID/Investigator# 112875

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Duarte : City of Hope National Medical Center Updated

A Phase 3 clinical study for patients with AML

Duarte : City of Hope National Medical Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Duarte : City of Hope National Medical Center

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Escondido : California Cancer Associates for Research and Excellence (cCare)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fountain Valley : Pacific Coast Hematology/Oncology Medical Group, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fountain Valley : Robert A. Moss, M.D. FACP, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fountain Valley : Lalita Pandit, MD, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fullerton : Virginia K. Crosson Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

La Jolla : Moores Cancer Center, UCSD

A clinical research study of A6 for the treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL or SLL

La Jolla : UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center

A clinical trial seeking patients for a research study for the treatment of Acute Lymphocytic Leukemia or Adult Lymphoblastic Lymphoma

La Jolla :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

La Jolla : Scripps Cancer Center

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Leukemia

La Jolla : Moores Cancer Center UCSD

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

La Jolla : Site Reference ID/Investigator# 91793

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

La Jolla :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

La Jolla : University of California San Diego

A clinical trial to evaluate treatments using Lenalidomide and Rituximab for patients

La Jolla : UC San Diego Moores Cancer Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

La Jolla : UCSD Medical Center / Thornton Hospital

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

La Jolla : Site Reference ID/Investigator# 128535

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Loma Linda : Loma Linda University Health Oncology

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Long Beach : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Los Angeles : Childrens Hospital Los Angeles

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Los Angeles : Children's Hospital Los Angeles Children's Hospital LA

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Los Angeles : UCLA Division of Hematology-Oncology

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Los Angeles : Childrens Hospital Los Angeles

A clinical trial to evaluate treatments for patients with Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma or Peripheral T-cell Lymphoma

Los Angeles : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Los Angeles : Cedars-Sinai Medical Center

A clinical trial to evaluate treatments using CC-115 for patients

Los Angeles : UCLA

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Los Angeles : UCLA Medical Center Updated

A Phase 3 clinical study for patients with AML

Los Angeles : Site Reference ID/Investigator# 127262

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Los Angeles : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles : Metropolitan Hematology Oncology Medical Group

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Los Angeles : Childrens Hospital Los Angeles

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Madera : Children's Hospital Central California

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Monterey : Monterey Bay Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Oceanside : North County Oncology

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Orange : Children's Hospital of Orange County CHOC

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Orange : Children's Hospital Orange County

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Oxnard : Ventura County Hematology Oncology Specialists

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Palo Alto : Lucile Salter Packard Children's Hospital at Stanford

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Palo Alto : Stanford University Medical Center

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Palo Alto :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Palo Alto : Stanford University Medical Center Oncology

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Pismo Beach : PCR Oncology

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Pleasant Hill : Bay Area Cancer Research Group, LLC (BIMAL PATEL)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pleasant Hill : Bay Area Cancer Research Group, LLC (OSTAP MELNYK)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pleasant Hill : Bay Area Cancer Research Group, LLC (ROBERT ROBLES)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pleasant Hill : Bay Area Cancer Research Group, LLC (JOHN GANEY)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Rancho Mirage : Cancer and Blood Institute Medical Group

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Riverside : Compassionate Cancer Care Medical Group (Riverside)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Roseville : Capitol Hematology Oncology Medical Group - Sutter Roseville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Sacramento : Site Reference ID/Investigator# 129719

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Sacramento :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Sacramento : UC Davis Cancer Center Updated

A Phase 3 clinical study for patients with AML

Sacramento : University of California Davis Cancer Center UC Davis Cancer (3)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Sacramento : University of California Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of Lenalidomide to evaluate Acute Leukemia

Sacramento : University of California Davis

Patients are needed to participate in a clinical research study of Lenalidomide to evaluate Acute Myeloid Leukemia or Myelodysplastic Syndrome

San Diego : Kaiser Permanente - California Southern Onc

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

San Diego : Sharp Memorial Hospital

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

San Francisco : UCSF School of Medicine

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

San Francisco : University of California at San Francisco

A clinical trial to evaluate treatments using CC-115 for patients

San Francisco : UCSF School of Medicine

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Santa Monica : Sarcoma Oncology Center

A clinical trial to evaluate treatments using NRX 195183 Soft Gelatin Capsule for patients with Acute Promyelocytic Leukemia

Santa Rosa : Redwood Regional Medical Group, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Stanford :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

Stanford : Site Reference ID/Investigator# 105117

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Stanford : Stanford University School of Medicine

A clinical trial to evaluate treatments using Lenalidomide for patients with Anemia, Leukemia, Leukemia, Myelocytic, Acute or Dysmyelopoietic Syndromes

Stanford : Site Reference ID/Investigator# 126495

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Stockton : St. Teresa Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Thousand Oaks : Ashwin Kashyap MD, INC.

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Vista : Medical Group of North County

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Colorado

Aurora : Site Reference ID/Investigator# 127859

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Aurora : University of Colorado Cancer Center

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Aurora : Children's Hospital Colorado

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Aurora : Children's Hospital Colorado

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Aurora : US Oncology - Rocky Mountain Cancer Center - Aurora

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Aurora : The Children's Hospital, University of Colorado

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Boulder : US Oncology - Rocky Mountain Cancer Center - Boulder

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Boulder : Rocky Mountain Cancer Centers, LLP

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Colorado Springs : US Oncology - Rocky Mountain Cancer Center - At the Pavillion

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Colorado Springs : US Oncology - Rocky Mountain Cancer Center - CO Springs

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Colorado Springs : The Oncology Clinic, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Denver : Colorado Blood Cancer Institute/Sarah Cannon Research Institute

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Denver :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

Denver :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Denver : US Oncology - Rocky Mountain Cancer Center - Midtown

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Denver : US Oncology - Rocky Mountain Cancer Center - Rose

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Denver : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Denver : Colorado Blood Cancer Institute

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Denver : Mile High Oncology

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Lakewood : US Oncology - Rocky Mountain Cancer Center - Lakewood

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Littleton : US Oncology - Rocky Mountain Cancer Center - Littleton

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lone Tree : US Oncology - Rocky Mountain Cancer Center - Sky Ridge

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Longmont : US Oncology - Rocky Mountain Cancer Center - Longmont

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Parker : US Oncology - Rocky Mountain Cancer Center - Parker

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pueblo : US Oncology - Rocky Mountain Cancer Center - Pueblo

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Thornton : US Oncology - Rocky Mountain Cancer Center - Thornton

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Connecticut

Manchester : Medical Oncology and Blood Disorders, LLP

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Britain : Hospital of Central Connecticut

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Haven : Yale University Updated

A Phase 3 clinical study for patients with AML

New Haven : Yale University School of Medicine Smilow Cancer Hospital

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Southington : Cancer Center of Central Connecticut

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Southington : Cancer Center of Central Connecticut

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Stamford : Stamford Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Stamford : Stamford Hospital Med. Oncology Hematology Res.

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Delaware

Newark : Delaware Clinical & Laboratory Physicians, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

District of Columbia

Washington : Children's National Medical Center

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Washington : Site Reference ID/Investigator# 96954

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Washington : Site Reference ID/Investigator# 127261

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Washington : Children's National Medical Center

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Florida

Atlantis : Medical Specialists of the Palm Beaches

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Boynton Beach : University Cancer Institute

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Boynton Beach : University Cancer Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Boynton Beach : Collaborative Research Group

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Boynton Beach : Palm Beach Institute of Hematology and Oncology

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fort Lauderdale : Broward Oncology Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Myers : Lee Memorial Health System

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Fort Myers : Florida Cancer - Colonial

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Gainesville : University of Florida

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Gainesville : Florida Cancer Specialists & Research Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hollywood : Memorial Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Jacksonville : Cancer Specialists of North Florida

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Jacksonville :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

Jacksonville : University of Florida College of Medicine - Jacksonville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Jacksonville : Baptist Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Jacksonville : Integrated Community Oncology Network

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Kissimmee : Osceola Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Lakeland : Watson Clinic Center for Cancer Care and Research

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Lakeland : Watson Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lecanto : Cancer & Blood Disease Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Miami : University of Miami Cancer Center

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Miami :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Miami : University of Miami Cancer Center

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

New Port Richey : Pasco Hernando Oncology Associates (Kumar)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Port Richey : Florida Cancer Specialists

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Port Richey : Pasco Hernando Oncology Associates, PA

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

New Port Richey : Pasco Pinellas Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Orlando : Nemours Children's Hospital

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Orlando : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Pensacola : Sacred Heart Medical Oncology Group

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Pensacola : Sacred Heart Medical Oncology Group

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Rockledge : Cancer Care Centers of Brevard

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Rockledge : Cancer Care Centers of Brevard

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Sarasota : Florida Cancer Specialists/Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating PRT062070 for the treatment of Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or B-cell Non Hodgkin Lymphoma (NHL)

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical research study of Ruxolitinib for the treatment of Myelomonocytic Leukemia

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Tampa : Moffitt Cancer Center & Research Institute

A clinical trial to evaluate treatments using CC-115 for patients

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Tampa :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Tampa : H. Lee Moffitt Cancer Center

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study to evaluate Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Tavares : Lake County Oncology & Hematology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

West Palm Beach : St. Mary's Hospital

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Georgia

Albany : Phoebe Putney Memorial Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Atlanta : Piedmont Cancer Institute, P.C. (was Peachtree Hematology-Oncology Consultants)

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Atlanta : Emory University-Winship Cancer Institute

A clinical research study of CDX-301 with or without plerixafor

Atlanta : Emory University, Winship Cancer Institute

A clinical research study of eltrombopag olamine and standard follow-up care

Atlanta : Children's Healthcare of Atlanta, Emory University

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Atlanta : Emory Children's Healthcare of Atlanta

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Atlanta : Northside Hospital

A clinical trial seeking patients for a research study of MLN9708

Atlanta : Children's Healthcare of Atlanta

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Atlanta : Winship Cancer Institute

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Atlanta : Georgia Cancer Specialists

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Atlanta : Emory University

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Atlanta : Peachtree Hematology-Oncology Consultants

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Atlanta : Emory University, Winship Cancer Institute

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Atlanta : Winship Cancer Institute, Emory University

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Atlanta : Emory Winship Cancer Institute Updated

A Phase 3 clinical study for patients with AML

Atlanta : Northside Hospital

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Atlanta : Children's Healthcare of Atlanta, Emory University

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Augusta : Georgia Health Sciences University

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Augusta : Augusta Oncology Associates, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Dublin : US Oncology - Dublin Hematology & Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Griffin : Spalding Oncology Services

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Lawrenceville : Gwinnett Hospital System Dba The Center for Cancer Care

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Marietta : Northwest Georgia Oncology Centers, P.C.

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Marietta : Northwest Georgia Oncology Centers, P.C.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Marietta : Northwest Georgia Oncology Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Newnan : Southeastern Regional Medical Center

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Thomasville : Lewis Hall Singletary Oncology Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hawaii

Honolulu : Straub Clinic and Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Honolulu : Kaiser Permanente Hawaii Moanalua Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Idaho

Boise : Saint Alphonsus Regional Medical Center

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Boise : St Luke's Mountain States Tumor Institute

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Illinois

Arlington Heights : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chicago : University of Chicago Medicine

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Chicago : Northwestern University

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Chicago : Site Reference ID/Investigator# 128742

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Chicago : Northwestern University

A clinical research study of alemtuzumab, ofatumumab and biopsy for the treatment of Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia or Stage IV Chronic Lymphocytic Leukemia

Chicago : Lurie Children's Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago Dept of Oncology

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Chicago : Northwestern University Feinberg School of Medicine

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Chicago : University of Chicago Cancer Research Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Chicago : Rush University Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Chicago : Rush University Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chicago : Northwestern Univ and Robert H. Lurie Comprehensive Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chicago : John H. Stroger, Jr., Hospital of Cook County

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chicago : Site Reference ID/Investigator# 92499

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Chicago : Site Reference ID/Investigator# 96960

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Chicago : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Chicago : Northwestern University Fienberg School of Medicine

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Chicago : University of Chicago

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago Ann&Robert Lurie

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Chicago : University of Chicago Updated

A Phase 3 clinical study for patients with AML

Chicago : Northwestern Medical Faculty Foundation Updated

A Phase 3 clinical study for patients with AML

Chicago : Site Reference ID/Investigator# 126497

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Chicago : John H. Stroger, Jr. Hospital of Cook County

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Chicago : Children's Memorial Hospital

Patients are needed to participate in a clinical research study evaluating Extracorporeal Photopheresis for the treatment of Leukemia or Cancer

Chicago : Northwestern University Feinberg School of Medicine

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Chicago : Northwestern University Feinberg School of Medicine

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Chicago : Northwestern Medical Faculty Foundation

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Chicago : Northwestern University

Patients are needed to participate in a clinical research study of EPZ-5676

Chicago : Lurie Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Gurnee : Oncology Hematology Assoc. of Northern Illinois

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Harvey : Ingalls Cancer Research Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Harvey : Site Reference ID/Investigator# 92497

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Harvey :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Joliet :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Lombard : Elmhurst Memorial Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Niles : Oncology Specialists, S.C.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Niles : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Niles : Illinois Cancer Specialists

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Peoria : Illinois Cancer Care

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Skokie : Orchard Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Urbana : Carle Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Winfield : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Indiana

Anderson : St. Vincent Anderson Regional Hospital Research

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Bloomington : IU health Bloomington Hospital

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Goshen : Center for Cancer Care @ Goshen Health Systems

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Indianapolis : Indiana Blood and Marrow Transplant

A clinical research study of CDX-301 with or without plerixafor

Indianapolis : Franciscan Saint Francis Health

A clinical research study of CPX-351 for the treatment of Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS)

Indianapolis : Riley Hospital for Children Oncology

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Indianapolis : St. Francis Cancer Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Indianapolis : Indiana University Cancer Center Clinical Research Office

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Indianapolis : Indiana Blood and Marrow Transplantation Clinic

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Indianapolis : Indiana University Riley Hospital for Children

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Indianapolis : Franciscan Alliance Updated

A Phase 3 clinical study for patients with AML

Indianapolis : Indiana Blood & Marrow Transplantation

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Indianapolis : Indiana University Indiana Univ. - Purdue Univ.

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Indianapolis : Indiana Blood and Marrow Transplantation Clinic

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Indianapolis : Indiana Oncology Hematology Consultants

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Lafayette : Arnett Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Mishawaka : Cancer Care Partners, LLC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Albany : Cancer Care Center, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Albany : Cancer Care Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Newburgh : Oncology Hematology Associates of Southwest Indiana

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

South Bend : Northern Indiana Cancer Research Consortium No. Indiana Cancer Res.

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Iowa

Ames : McFarland Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bettendorf : Hematology Oncology Associates of the Quad Cities

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Cedar Rapids : Iowa Blood and Cancer Care of PCI

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Cedar Rapids : Iowa Blood and Cancer Care of PCI

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Waterloo : Covenant Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kansas

Overland Park : Kansas City Cancer Center KCCC Business Office

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Westwood : University of Kansas Cancer Center

A clinical research study of CPX-351 for the treatment of Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS)

Wichita : Cancer Center of Kansas, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kentucky

Hazard : Kentucky Cancer Clinic

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Louisville : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Louisiana

Baton Rouge : Mary Bird Perkins Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Baton Rouge : Hematology Oncology Clinic, PLLC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Lafayette : Cancer Center of Acadiana at Lafayette General Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

New Orleans : Ochsner Clinic Foundation Oshsner Medical Center

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Maryland

Baltimore : Site Reference ID/Investigator# 129699

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Baltimore : Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

A clinical research study of Ruxolitinib for the treatment of Myelomonocytic Leukemia

Baltimore : Johns Hopkins University

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Baltimore : Johns Hopkins Oncology Center ORA

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Baltimore : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Baltimore : University of Maryland Updated

A Phase 3 clinical study for patients with AML

Baltimore : St. Agnes Hospital St. Agnes Hospital (2)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Baltimore : Johns Hopkins University

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Baltimore : Chesapeake Oncology Hematology Associates

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Baltimore : Auerbach Hematology Oncology Associates, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Baltimore : Greater Baltimore Medical Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Baltimore : Johns Hopkins University

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Bethesda : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Bethesda : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike

Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide

Cumberland : Western Maryland Health System

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Cumberland : Western Maryland Health System, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Massachusetts

Boston : Site Reference ID/Investigator# 127857

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Boston : Dana Farber

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Boston : Dana Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Boston : Massachusetts General Hospital

A clinical trial seeking patients for a research study for the treatment of Relapsed Acute Myeloid Leukemia or Refractory Acute Myeloid Leukemia

Boston : Dana-Farber Cancer Institute

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Boston : Site Reference ID/Investigator# 92494

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Boston : Beth Israel Deaconess Medical Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Boston : Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

A clinical trial to evaluate treatments using Lenalidomide and Rituximab for patients

Boston : Massachusetts General Hospital

A clinical trial to evaluate treatments using Lenalidomide, HLA-mismatched stem-cell Microtransplantation and Cytarabine for patients

Boston : Massachusetts General Hospital

A Phase 1 clinical study for patients with Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, B-cell Adult Acute Lymphoblastic Leukemia or T-cell Adult Acute Lymphoblastic Leukemia

Boston : Dana Farber Cancer Institute Hematology / Oncology

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Boston : Boston Children's Hospital

A Phase 1 clinical study for patients with Relapsed Acute Lymphoblastic Leukemia (ALL), Refractory Acute Lymphoblastic Leukemia (ALL), Relapsed Acute Myelogenous Leukemia (AML) or Refractory Acute Myelogenous Leukemia (AML)

Boston : Dana-Farber Cancer Institute

A Phase 1 clinical study for patients with Relapsed Acute Lymphoblastic Leukemia (ALL), Refractory Acute Lymphoblastic Leukemia (ALL), Relapsed Acute Myelogenous Leukemia (AML) or Refractory Acute Myelogenous Leukemia (AML)

Boston : Dana Farber Cancer Institute Updated

A Phase 3 clinical study for patients with AML

Boston : Site Reference ID/Investigator# 134509

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Boston : Site Reference ID/Investigator# 126496

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Boston : Brigham & Women's Hospital

Patients are needed to participate in a clinical research study evaluating Cordycepin plus Pentostatin for the treatment of Refractory TdT-Positive Leukemia

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Cordycepin plus Pentostatin for the treatment of Refractory TdT-Positive Leukemia

Boston : Tufts Medical Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating IPI-145, Fludarabine, Cyclophosphamide and Rituximab for the treatment of Chronic Lymphocytic Leukemia

Boston : Dana-Farber Cancer Institute/Brigham and Women's Hospital

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study of Ibrutinib, Fludarabine, Cyclophosphamide and Rituximab to evaluate Chronic Lymphocytic Leukemia

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study of Ibrutinib, Fludarabine, Cyclophosphamide and Rituximab to evaluate Chronic Lymphocytic Leukemia

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Boston : Dana Farber

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Burlington : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Hyannis : Capecod Hospital / Davenport Mugar Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Worcester : University of Massachusetts Medical School

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Worcester : University of Massachusetts Worcester

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Worcester : Fallon Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Worcester : University of Massachusetts Worcester

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Michigan

Ann Arbor : University of Michigan Comprehensive Cancer Center

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Ann Arbor : C.S. Mott Children's Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Ann Arbor : Site Reference ID/Investigator# 102856

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Ann Arbor : University of Michigan

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Ann Arbor : University of Michigan Health System

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Ann Arbor : University of Michigan Comprehensive Cancer Center SC

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Ann Arbor : University of Michigan Health System Updated

A Phase 3 clinical study for patients with AML

Ann Arbor : St. Joseph Mercy Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Ann Arbor : University of Michigan Health System

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Ann Arbor : University of Michigan Health System

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Ann Arbor : C.S. Mott Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Bay City : Michigan State University/Bay Regional Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Detroit :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Detroit : Karmanos Cancer Institute

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Detroit : Barbara Ann Karmanos Cancer Institute Updated

A Phase 3 clinical study for patients with AML

Detroit : Karmanos Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Flint : Michigan State University / McLaren Regional Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Flint : Genesys Hurley Cancer Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Flint : Genesee Cancer & Blood Disease Treatment Center, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Freesoil : West Michigan Regional Cancer & Blood Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Grand Rapids : Cancer and Hematology Centers of Western Michigan

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Grand Rapids : Spectrum Health Hospitals

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Kalamazoo : West Michigan Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lansing : Michigan State University/ Breslin Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lapeer : Michigan State University/ Lapeer Regional Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Mount Clemens : Michigan State University/ Mount Clemens Regional Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Owosso : Michigan State University/ Memorial Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Southfield : Providence Cancer Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Minnesota

Duluth : Essentia Health Oncology Clinical Trials

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Duluth : Duluth Clinic Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Minneapolis : Childrens Hospital & Clinics of Minnesota

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Minneapolis : University of Minnesota Medical Center, Fairview Oncology

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Minneapolis : University of Minnesota Medical Center

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Minneapolis : Novartis Investigative Site

A Phase 1/Phase 2 clinical study for patients using HSC835

Minneapolis : Childrens Hospital & Clinics of Minnesota

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Rochester : Mayo Clinic, Rochester

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Rochester : Mayo Clinic Updated

A Phase 3 clinical study for patients with AML

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

St. Louis Park : Metro MN CCOP/Park Nicollet Institute

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

St. Louis Park : Park Nicollet Institute - Louisiana Ave.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Louis Park : Park Nicollet Institute Metro - MN CCOP

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Louis Park : Metro Minnesota Community Clinical Oncology Program

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Woodbury : Minnesota Oncology Hematology, PA

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Mississippi

Hattiesburg : Hattiesburg Clinic

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Jackson : University of Mississippi Medical Center Peds Heme/Onc

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Southaven : US Oncology - University of Tennessee Cancer Institute - Southaven

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tupelo : North Mississippi Hematology and Oncology Assoc., Ltd.

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Missouri

Branson : Branson Oncology Clinic

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Columbia : US Oncology - Missouri Cancer Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Jefferson City : Capitol Comprehensive Cancer Care Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kansas City : Research Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kansas City : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Kansas City : Mercy Children's Kansas University

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Kansas City : Research Medical Center Research Med Center (2)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Kansas City : Children's Mercy Hospitals and Clinics

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Springfield : St. John's Medical Research Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Joseph : St. Joseph Oncology, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Joseph : Heartland Regional Medical Center

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

St. Louis : Washington University School of Medicine

A clinical trial seeking patients for a research study for the treatment of AML

St. Louis : Hematology Oncology Consultants, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Louis : Washington University School of Medicine

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

St. Louis : Washington University School of Medicine Updated

A Phase 3 clinical study for patients with AML

St. Louis : Washington University Medical School

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

St. Louis : Washington University School of Medicine Washington University (16)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

St. Louis : St. Louis Hematology Oncology Specialists, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Montana

Missoula : Montana Cancer Institute Foundation

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Nebraska

Lincoln : Nebraska Hematology Oncology, PC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Omaha : University of Nebraska Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Omaha : Nebraska Medical Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Omaha : Nebraska Methodist Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Omaha : Oncology Hematology West PC dba Nebraska Cancer Specialists

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Nevada

Carson City : Sierra Nevada Oncology Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Las Vegas : Southern Nevada Cancer Research Foundation

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Las Vegas : Nevada Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Reno : VA Sierra Nevada Healthcare System

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Jersey

Cherry Hill : The Center for Cancer and Hematologic Disease

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Cherry Hill : The Center for Cancer and Hematologic Disease

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Elizabeth : Ellioth Fishkin, MD

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Englewood : Drs. Forte, Schleider, Attas & Condemi, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hackensack : Hackensack University Medical Center

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Hackensack : The Cancer Center at Hackensack University Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Hackensack : Hackensack University Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hackensack : Site Reference ID/Investigator# 92500

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Hackensack : Hackensack University Medical Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Hackensack : Hackensack University Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Morristown : Hematology Oncology of Northern New Jersey

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Morristown : Hematology Oncology Associates of Northern New Jersey

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

New Brunswick : Rutgers Cancer Institute of New Jersey (CINJ)

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

New Brunswick : Saint Peter's University Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Brunswick : Site Reference ID/Investigator# 92513

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Somerville : Steeplechase Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Sparta : Sparta Cancer Center

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

New Mexico

Albuquerque : New Mexico Cancer Care Alliance Oncology Dept

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Albuquerque : Cancer Center at Presbyterian

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Farmington :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Farmington : San Juan Oncology Associates

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

New York

Albany : Samuel S Stratton VAMC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bay Shore : Hematology Oncology Associates of Western Suffolk

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bronx : Children's Hospital at Montefiore

A clinical trial seeking patients for a research study of Aromatherapy Scented Wand and Placebo wand

Bronx : Eastchester Center for Cancer Care

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bronx : Bronx River Medical Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bronx : Montefiore Medical Center

Patients are needed to participate in a clinical research study of Liposomal Annamycin to evaluate Acute Lymphocytic Leukemia

Bronxville : Eduardo Saponara, MD

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Buffalo : Roswell Park Cancer Institute

A clinical research study of eltrombopag olamine and standard follow-up care

Buffalo :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Buffalo : Roswell Park Cancer Institiute

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Buffalo : Jonah Cancer Care Center & ECMC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Buffalo : Roswell Park Cancer Institute

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Buffalo : Roswell Park Cancer Institute Updated

A Phase 3 clinical study for patients with AML

Buffalo : Roswell Park Cancer Institute

Patients are needed to participate in a clinical research study evaluating DEC-205/NY-ESO-1 fusion protein CDX-1401, poly ICLC, decitabine and laboratory biomarker analysis

Buffalo : Roswell Park Cancer Institute

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Buffalo : Roswell Park Cancer Institute Updated

Patients are needed to participate in a clinical research study of cytarabine, omacetaxine mepesuccinate, decitabine and laboratory biomarker analysis

Buffalo : Roswell Park Cancer Institute

Patients are needed to participate in a clinical research study of Liposomal Annamycin to evaluate Acute Lymphocytic Leukemia

Glens Falls : C.R. Wood Cancer Center at Glens Falls Hospital

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Hawthorne : New York Medical College

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Johnson City : Broome Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lake Success : Clinical Research Alliance

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Lake Success : North Shore-LIJ Health System Monter Cancer Center

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Mineola : Winthrop University Hospital Oncology/ Hematology

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Mount Kisco : Westchester Hematology Oncology Associates

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

New Hyde Park : Long Island Jewish Medical Center

A clinical trial to evaluate treatments using Lenalidomide and Rituximab for patients

New York : New York Presbyterian Hospital / Weill Cornell Medical College

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

New York : Site Reference ID/Investigator# 130289

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

New York : Memorial Sloan Kettering

A clinical research study of Cytarabine, Lintuzumab-Ac225, Lasix and Spironolactone for the treatment of Leukemia

New York : Children's Hospital New York-Presbyterian

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

New York : New York University Medical Center

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

New York : Weill Medical College of Cornell

A clinical research study of Ruxolitinib for the treatment of Myelomonocytic Leukemia

New York : GSK Investigational Site

A clinical trial seeking patients for a Cancer treatment research study

New York :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

New York : Memorial Sloan Kettering Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

New York : Columbia University Medical Center

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

New York : Site Reference ID/Investigator# 103835

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

New York : Site Reference ID/Investigator# 94716

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

New York : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using CC-115 for patients

New York : Weill Cornell Medical College

A clinical trial to evaluate treatments using CPX-351 for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

New York : Weill Cornell-New York Presbyterian Hospital

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using Oral Azacitidine for patients with Leukemia, Myeloid, Acute or Myelodysplastic Syndromes

New York : Cornell

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

New York : Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

New York : Columbia University Medical Center Updated

A Phase 3 clinical study for patients with AML

New York : Site Reference ID/Investigator# 128536

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

New York : Beth Israel Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York : Weill Cornell Medical College

Patients are needed to participate in a clinical research study evaluating plerixafor and decitabine for the treatment of Acute Myeloid Leukemia

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

New York : Weill Cornell Medical Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study of EPZ-5676

New York : Mount Sinai Medical Center

Patients are needed to participate in a clinical research study of oral rigosertib and Azacitidine to evaluate Myelodysplastic Syndrome, Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study of Palifermin, Lupron, without the addition of palifermin or Lupron and peripheral blood stem cell transplantation to evaluate Leukemia, Multiple Myeloma, Myelodysplastic Syndrome or Non-Hodgkin's Lymphoma

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

New York : Children's Hospital New York-Presbyterian

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

New York : New York University Medical Center

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Rochester : Rochester General Hospital

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Rochester : University of Rochester Updated

A Phase 3 clinical study for patients with AML

Rochester : Site Reference ID/Investigator# 130011

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Rochester : University of Rochester

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Rochester : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Syracuse : SUNY Upstate Medical University - Adult Program

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Syracuse : SUNY Upstate Medical University

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Valhalla : Westchester Medical Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Valhalla : NY Medical College Updated

A Phase 3 clinical study for patients with AML

North Carolina

Cary : US Oncology - Cancer Centers of North Carolina - Cary

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chapel Hill : UNC Healthcare

A clinical trial seeking patients for a research study for the treatment of Chronic Myeloid Leukemia

Chapel Hill : UNC Chapel Hill

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Chapel Hill : UNC Linebreger Comprehensive Cancer Center Updated

A Phase 3 clinical study for patients with AML

Chapel Hill : University of North Carolina

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Chapel Hill : University of N.C. at Chapel Hill Physician Office Building

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Chapel Hill : University of North Carolina at Chapel Hill - Lineberger Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of Lenalidomide to evaluate Acute Myeloid Leukemia

Charlotte : Levine Children's Hospital at Carolinas Medical Center

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Charlotte : Carolinas Medical Center

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Charlotte : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Charlotte : Levine Children's Hospital at Carolinas Medical Center

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Durham : Duke University Medical Center

A clinical research study of NiCord® for the treatment of Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Durham : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Durham : Duke University Medical Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Durham : Duke University Medical Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia

Durham : Duke University Health System

Patients are needed to participate in a clinical research study of EPZ-5676

Durham : Duke University

Patients are needed to participate in a clinical research study of SG2000 to evaluate Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

Hickory : Carolina Oncology Specialists, PC

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Pinehurst : FirstHealth Outpatient Cancer Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Raleigh : Rex Cancer Center - Wakefield

A clinical trial seeking patients for a research study for the treatment of Chronic Myeloid Leukemia

Raleigh : Rex Cancer Center

A clinical trial seeking patients for a research study for the treatment of Chronic Myeloid Leukemia

Raleigh : US Oncology - Cancer Centers of North Carolina - Falls

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Raleigh : US Oncology - Cancer Centers of North Carolina - Macon

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Winston-Salem : Wake Forest University Baptist Health Updated

A Phase 3 clinical study for patients with AML

North Dakota

Bismarck : Legacy Pharma Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bismarck : Mid Dakota Clinic/Odyssey Research

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fargo : Roger Maris Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Ohio

Akron : Summa Health System

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Akron : Summa Health System - Cancer Research Office

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Akron : Summa Health System Hospitals

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Canton : Gabrail Cancer Center

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Canton : Gabrail Cancer Center Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Canton : Nashat Y. Gabrail, MD, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Cincinnati : Cincinnati Children's Hospital Medical Center

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Cincinnati : Cincinnati Children's Hospital Medical Center Cin. Children's Hosp Med Ctr

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Cincinnati : Cincinnati Children's Hospital

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Cincinnati : Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Cincinnati : University of Cincinnati Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Cincinnati : Cincinnati Children's Hospital Medical Center

Patients are needed to participate in a clinical research study evaluating CPX-351 in Children With Relapsed Acute Myeloid Leukemia (AML)

Cincinnati : Oncology Hematology Care

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Cleveland : Rainbow Babies

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Cleveland : University Hospitals Case Medical Center

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Cleveland : Cleveland Clinic

A clinical research study of Ruxolitinib for the treatment of Myelomonocytic Leukemia

Cleveland : Rainbow Babies & Children's Hospital RB&C 340

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Cleveland : Site Reference ID/Investigator# 108136

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Cleveland : Site Reference ID/Investigator# 92495

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Cleveland : Case Western

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Cleveland :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Cleveland : University Hospitals Case Medical Center

A clinical trial to evaluate treatments using Oral Azacitidine for patients with Leukemia, Myeloid, Acute or Myelodysplastic Syndromes

Cleveland : Cleveland Clinic

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Cleveland : Cleveland Clinic

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Cleveland : Cleveland Clinic Taussig Cancer Institute

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Cleveland : Cleveland Clinic Foundation

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Cleveland : Cleveland Clinic, The

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Cleveland : Rainbow Babies

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Columbus : Ohio State University Comprehensive Cancer Center

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Columbus : Nationwide Childrens Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Columbus :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Columbus : Nationwide Children's Hospital

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Columbus : Mid Ohio Oncology / Hematology, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Columbus : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

A clinical trial to evaluate treatments using MOR00208, lenalidomide and Correlative Studies for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL

Columbus : Site Reference ID/Investigator# 127263

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

Patients are needed to participate in a clinical research study evaluating decitabine, selinexor, pharmacological study and laboratory biomarker analysis for the treatment of Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia or Untreated Adult Acute Myeloid Leukemia

Columbus : Nationwide Childrens Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Elyria : Hematology Oncology Center, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Oregon

Eugene : US Oncology - Willamette Valley Cancer Institute - Eugene

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Portland : Oregon Health and Science University

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Broadway

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Hoyt

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Barnes

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Portland : Oregon Health & Science University SC-6

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Portland : Oregon Health & Science University

A Phase 2 clinical study for patients with Acute Myelogenous Leukemia or Acute Lymphoblastic Leukemia

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Portland : OHSU Knight Cancer Institute

Patients are needed to participate in a clinical research study of Dasatinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Salem : Salem Health

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Salem : Salem Health

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Springfield : US Oncology - Willamette Valley Cancer Institute - Springfield

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Springfield : Williamette Valley Cancer Center and Research Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Tualatin : US Oncology - Northwest Cancer Specialists, PC - Tualatin

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pennsylvania

Bethlehem : Oncology Hematology of Lehigh Valley

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Danville : Geisinger Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Drexel Hill : Consultants in Medical Oncology and Hematology, PC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Gettysburg : Gettysburg Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Gettysburg : Gettysburg Cancer Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Hershey : Milton S. Hershey Medical Center / Penn State

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Hershey : Penn State Hershey Cancer Institute

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Hershey : Penn State Milton S. Hershey Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Hershey : Penn State Milton S Hershey Medical Center Updated

A Phase 3 clinical study for patients with AML

Kingston : US Oncology - Medical Oncology Associates (Nahar)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lancaster : Lancaster Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Norristown : Luitpold Pharmaceuticals, Inc.

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia

Philadelphia : Temple BMT Program at Jeanes Hospital

A clinical research study of Decitabine, Carboplatin and Arsenic trioxide for the treatment of Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Philadelphia : Abramson Cancer Center of the University of Pennsylvania

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Philadelphia : Hospital of the University of Pennsylvania

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Philadelphia : Drexel University College of Medicine

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Philadelphia : Thomas Jefferson University Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Philadelphia : Children's Hospital of Philadelphia

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Philadelphia : University of Pennsylvania Health System Updated

A Phase 3 clinical study for patients with AML

Philadelphia : Site Reference ID/Investigator# 126860

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study evaluating Bendamustine, Pentostatin and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or B-Cell Non-Hodgkin's Lymphoma

Philadelphia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Philadelphia : Temple University Bone Marrow Transplant Program

Patients are needed to participate in a clinical research study evaluating Decitabine, Carboplatin and Arsenic Trioxide for the treatment of Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Pittsburgh : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Pittsburgh : UPMC Cancer Center - Hillman Cancer Center

A clinical trial to evaluate treatments using Neukoplast™ (NK-92) for patients with Acute Myeloid Leukemia

Pottstown : Pottstown Memorial Regional Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Reading : Berks Hematology Oncology Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Rhode Island

Cranston : Hematology & Oncology Associates of Rhode Island

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Cranston : Sambandam and Joseph Associates, Inc

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Providence : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Providence : Rhode Island Hospital Rhode Island Hosp. (2)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

South Carolina

Charleston : Charleston Hematology Oncology Associates, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Charleston : MUSC- Hollings Cancer Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Charleston : Charleston Hematology Oncology, PA

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Charleston : Medical University of South Carolina

Patients are needed to participate in a clinical research study of SG2000 to evaluate Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

Columbia : South Carolina Oncololgy Associates, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Columbia : South Carolina Oncology Associates

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Easley : US Oncology - Cancer Centers of the Carolinas - Easley

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Greenville : US Oncology - Cancer Centers of the Carlinas - Eastside

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Greenville : US Oncology - Cancer Centers of the Carolinas - West Faris

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Greenville : US Oncology - Cancer Centers of the Carolinas - Butternut

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Greenville : Greenville Health System Cancer Institute

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Greenville : Greenville Hospital System

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Greenville : Bon Secours Saint Francis Health System

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Seneca : US Oncology - Cancer Centers of the Carolinas - Seneca

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spartanburg : Spartanburg Regional Medical Center

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Spartanburg : US Oncology - Cancer Centers of the Carolinas - Spartanburg

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spartanburg : Spartanburg Regional Health Services District, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

South Dakota

Sioux Falls : Sanford Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Sioux Falls : Avera Cancer Institute Updated

A Phase 3 clinical study for patients with AML

Sioux Falls : Sanford Research Sanford Health

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Watertown : Prairie Lakes Health Systen, Inc

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Watertown : Prairie Lakes Health Care System, Inc.

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Tennessee

Bartlett : US Oncology - University of Tennessee Cancer Institute - Bartlett

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bristol : Wellmont Medical Associates Oncology and Hematology

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Chattanooga : Associates in Oncology and Hematology

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Chattanooga : Associates in Oncology and Hematology

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Chattanooga : Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Collierville : Family Cancer Center, PLLC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Collierville : The Family Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Germantown : US Oncology - University of Tennessee Cancer Institute - Germantown

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Germantown : Jones Clinic PC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Germantown : C. Michael Jones, MD, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Knoxville : University of Tennessee Medical Center Cancer Intitute

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Knoxville : East Tennessee Children's Hospital

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Memphis : St. Jude

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Memphis : St. Jude Children's Research Hospital

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukemia

Memphis : St. Jude's Children's Research Hospital Dept of Oncology

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Memphis : US Oncology - University of Tennessee Cancer Institute - Memphis

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Memphis : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Memphis : St. Jude Children's Research Hospital

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Memphis : St. Jude

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Nashville : Tennessee Oncology/Sarah Cannon Research Institute

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Nashville : Vanderbilt-Ingram Cancer Center / Vanderbilt University

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Nashville : Vanderbilt Children's Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Nashville : Vanderbilt University

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Nashville :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

Nashville :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Nashville : Vanderbilt U Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Nashville : SCRI

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Nashville : Sarah Cannon Research Institute (SCRI) Drug Development Unit

A clinical trial to evaluate treatments using CC-115 for patients

Nashville : Vanderbilt-Ingram Cancer Center Updated

A Phase 3 clinical study for patients with AML

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Nashville : Tennessee Oncology, PLLC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Nashville : Tennessee Oncology/Sarah Cannon Research Insitute

Patients are needed to participate in a clinical research study evaluating PRT062070 for the treatment of Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or B-cell Non Hodgkin Lymphoma (NHL)

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Nashville : Tennessee Oncology, PLLC

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study of EPZ-5676

Nashville : Vanderbilt Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Texas

Abilene : US Oncology - Texas Cancer Center - Abilene (South)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Amarillo : US Oncology - Texas Oncology, PA - Amarillo

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Arlington : US Oncology - Texas Oncology - Arlington South

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Arlington : Arlington Cancer Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Austin : Dell Children's Medical Center of Central Texas

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Austin : Texas Oncology-Austin Midtown

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Bedford : US Oncology - Texas Oncology, PA - Bedford

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bryan : St. Joseph Regional Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

College Station : Scott & White Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Corpus Christi : South Texas Institute of Cancer

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Corpus Christi : Coastal Bend Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Dallas : Charles A. Sammons Cancer Center / Baylor University Medical Center

A clinical research study of Standard dose cytarabine for induction, SGN-CD33A, Daunorubicin and High dose cytarabine for consolidation for the treatment of Acute Myeloid Leukemia or Acute Myelogenous Leukemia (AML)

Dallas : Children's Medical Center of Dallas Oncology

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Dallas : US Oncology - Texas Oncology, PA - Dallas

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Dallas : Mary Crowley Cancer Research Centers

A clinical trial to evaluate treatments using CC-115 for patients

Dallas : UTSW UT Southwestern Updated

A Phase 3 clinical study for patients with AML

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas : Texas Oncology-Medical City Dallas

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Dallas : Texas Oncology Presbyterian Hospital (3)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Dallas : University of Texas at Southwestern

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

El Paso : US Oncology - El Paso Cancer Treatment Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

El Paso : US Oncology - El Paso Cancer Treatment Center - West

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Sam Houston : San Antonio Military Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Worth : Cook Children's Medical Center Oncology

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Fort Worth : US Oncology - Southwest Fort Worth Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Worth : US Oncology - Texas Oncology, PA - Fort Worth

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Worth : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Fort Worth : JPS Center for Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fort Worth : Cook Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Galveston : University of Texas at Galveston

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Grapevine : US Oncology - Texas Oncology - Grapevine

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Houston : MD Anderson Cancer Center / University of Texas

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Houston : University of Texas MD Anderson Cancer Center

A clinical research study for the treatment of Leukemia or Acute Lymphoblastic Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study for the treatment of Myelodysplastic Syndrome or Leukemia

Houston : Site Reference ID/Investigator# 127860

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Cladribine and Rituximab for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Cytarabine, Lintuzumab-Ac225, Lasix and Spironolactone for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Dasatinib and Decitabine for the treatment of Leukemia

Houston : MD Anderson Cancer Center

A clinical research study of DFP-10917 for the treatment of Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Eltrombopag and Decitabine for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Lenalidomide for the treatment of Leukemia, Acute Myeloid Leukemia (AML)

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of MEK 162 for the treatment of Leukemia (AML)

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of MEK-162, Nilotinib and Questionnaires for the treatment of Leukemia, Refractory Leukemia, Advanced Chronic Myeloid Leukemia, Acute Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Ponatinib for the treatment of Leukemia (CML)

Houston : MD Anderson Cancer Center / University of Texas

A clinical research study of Standard dose cytarabine for induction, SGN-CD33A, Daunorubicin and High dose cytarabine for consolidation for the treatment of Acute Myeloid Leukemia or Acute Myelogenous Leukemia (AML)

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Vosaroxin and Decitabine for the treatment of Leukemia

Houston : GSK Investigational Site

A clinical trial seeking patients for a Cancer treatment research study

Houston :

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia or Myeloproliferative Diseases

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Lymphoma or Leukemia

Houston : The University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Houston : MD Anderson Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Houston : MD Anderson Cancer Center

A clinical trial to evaluate treatments using 100mg Crenolanib besylate, given three times daily for patients with Acute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior Therapies

Houston : Site Reference ID/Investigator# 92521

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Azacytidine and Sorafenib for patients with Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Brentuximab Vedotin and 5-Azacytidine for patients with Leukemia, Acute Myeloid Leukemia (AML)

Houston : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Houston : The University of Texas, MD Anderson Cancer Center

A clinical trial to evaluate treatments using CC-115 for patients

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Cytomegalovirus (CMV)-Specific Cytotoxic T Cells (CTLs) for patients with Leukemia or Lymphoma

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Eltrombopag for patients with Leukemia

Houston : MD Anderson Cancer Center

A clinical trial to evaluate treatments using FLX925 for patients with Acute Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Ibrutinib and Rituximab for patients with Leukemia

Houston : MD Anderson Cancer Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Houston :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Houston : M. D. Anderson Cancer Center at University of Texas

A clinical trial to evaluate treatments using Lenalidomide and Rituximab for patients

Houston : MD Anderson Cancer Center

A clinical trial to evaluate treatments using Oral Azacitidine for patients with Leukemia, Myeloid, Acute or Myelodysplastic Syndromes

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Quizartinib, Cytarabine and AZA for patients with Leukemia

Houston : The University of Texas, M.D. Anderson Cancer Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Houston : MD Anderson Cancer Center

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

A Phase 1 clinical study for patients with Leukemia

Houston : MD Anderson Cancer Center

A Phase 1/Phase 2 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Houston : University of Texas MD Anderson Cancer Center

A Phase 1/Phase 2 clinical study for patients with Leukemia

Houston : University of Texas MD Anderson Cancer Center

A Phase 1/Phase 2 clinical study for patients with Leukemia, Myeloma or Myeloproliferative Diseases

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Advanced Cancers or Leukemia

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Leukemia

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Leukemia or Lymphoma

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Leukemia, Myelodysplastic Syndrome (MDS)

Houston : MD Anderson Center, The University of Texas Updated

A Phase 3 clinical study for patients with AML

Houston : University of Texas MD Anderson Cancer Center

A Phase 3 clinical study for patients with Disorder Related to Bone Marrow Transplantation, Leukemia or Transplantation Infection

Houston : Site Reference ID/Investigator# 126498

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Houston : The University of Texas, MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Houston : The University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Decitabine, Carboplatin and Arsenic Trioxide for the treatment of Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Houston : M D Anderson

Patients are needed to participate in a clinical research study evaluating DS-3032b for the treatment of Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Eltrombopag and Hypomethylating Agent (HMA) for the treatment of Leukemia

Houston : MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Houston : Oncology Consultants Oncology Group

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Houston : University of Texas M.D. Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating PRI-724 for the treatment of Acute Myeloid Leukemia or Chronic Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Ruxolitinib for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating SGI-110, Idarubicin and Cladribine for the treatment of Leukemia

Houston : The University of Texas, MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Houston : UT MD Anderson Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia or Chronic Lymphocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia, Lymphoblastic Lymphoma or Leukemia, Lymphoblastic, Acute

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of ATRA, ATO, GO (Gemtuzumab ozogamicin) and Methylprednisolone to evaluate Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Azacitidine to evaluate Leukemia, AML or MDS

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Houston : The University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Houston : UT MD Anderson Cancer

Patients are needed to participate in a clinical research study of EPZ-5676

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Liposomal Annamycin to evaluate Acute Lymphocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Ofatumumab to evaluate Chronic Lymphocytic Leukemia

Houston : The University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of oral rigosertib and Azacitidine to evaluate Myelodysplastic Syndrome, Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Rasburicase and Allopurinol to evaluate Leukemia or Lymphoma

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Ruxolitinib and TKI to evaluate Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Ruxolitinib to evaluate Leukemia

Houston : MD Anderson Cancer Center / University of Texas

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study to evaluate Leukemia

Kerrville : US Oncology - San Antonio Tumor & Blood Clinic - Kerrville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Longview : US Oncology - Longview Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lubbock : Joe Arrington Cancer Research and Treatment Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

McAllen : US Oncology - Texas Oncology - McAllen

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Mesquite : US Oncology - Texas Oncology - Mesquite

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Midland : US Oncology - Allison Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Paris : US Oncology - Texas Oncology - Paris

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Round Rock : Scott & White Healthcare Deparment of Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

San Antonio : Texas Transplant Institute/Sarah Cannon Research Institute

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

San Antonio :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

San Antonio : US Oncology - San Antonio Tumor & Blood Clinic - M. Oak

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

San Antonio : US Oncology - Cancer Care Centers of South Texas

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

San Antonio : Texas Transplant Center at Methodist Healthcare System

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

San Antonio : Cancer Therapy Reasearch Center at UTHSCA

Patients are needed to participate in a clinical research study evaluating Cordycepin plus Pentostatin for the treatment of Refractory TdT-Positive Leukemia

San Antonio : Cancer Care Network of South Texas

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Sherman : US Oncology - Texas Oncology - Sherman

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tyler : ETMC dba Tyler Hematology Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tyler : US Oncology - Texas Oncology - Tyler

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tyler : ETMC dba Blood and Cancer Center - East Texas

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tyler : Texas Oncology

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Waco : US Oncology - Texas Oncology Cancer Care and Research Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Weslaco : US Oncology - Texas Oncology - Weslaco

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Wichita Falls : US Oncology - Texoma Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Utah

Logan : Cache Valley Cancer Treatment & Research Clinic, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Murray : Intermountain Medical Center Intermountain Healthcare

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Ogden : Northern Utah Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Salt Lake City : Primary Children's

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Salt Lake City : University of Utah

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Salt Lake City : Utah Cancer Specialists

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Salt Lake City : University of Utah, Huntsman Cancer Institute

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Salt Lake City : Utah Cancer Specialists Utah Cancer Specialists (11)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Salt Lake City : University of Utah

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Salt Lake City : Primary Children's

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Virginia

Abingdon : Cancer Outreach Associates, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Arlington : US Oncology - Arlington Fairfax Hematology Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Charlottesville : University of Virginia Medical Center

A clinical research study of CDX-301 with or without plerixafor

Christiansburg : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Christiansburg

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fairfax : US Oncology - Fairfax Northern VA Hem-Onc PC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fairfax : Virginia Cancer Specialists, PC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Gainesville : US Oncology - Fairfax - Northern Virginia Hematology-Oncology, PC - Gainesville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Leesburg : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Leesburg

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Low Moor : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Low Moor

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Norfolk : Virginia Oncology Associates

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Richlands : Virginia Oncology Care, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Richmond : Virginia Commonwealth University Medical Center

A clinical research study of CDX-301 with or without plerixafor

Richmond : Virginia Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Roanoke : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Roanoke

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Salem : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Salem

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Winchester : US Oncology - Shenandoah Oncology - Winchester

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Winchester : Shenandoah Oncology Shenadoah Oncology (2)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Woodbridge : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Woodbridge

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Wytheville : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Wytheville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Washington

Bellingham : PeaceHealth St Joseph Cancer Center

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Bellingham : Peace Health Medical Group

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Edmonds : US Oncology - Puget Sound Cancer Center - Edmonds

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Everett : Providence Everett Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kennewick : Columbia Basin Hematology and Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kennewick : Columbia Basin Hematology and Oncology

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Kennewick : Columbia Basin Hematology & Oncology Columbia Basin

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Seattle : Seattle Children's Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Seattle : Fred Hutchinson Cancer Research Center

A clinical research study of Standard dose cytarabine for induction, SGN-CD33A, Daunorubicin and High dose cytarabine for consolidation for the treatment of Acute Myeloid Leukemia or Acute Myelogenous Leukemia (AML)

Seattle : Seattle Children's Hospital

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Seattle : US Oncology - Puget Sound Cancer Center - Seattle

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Seattle : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Seattle : Fred Hutchinson Cancer Research Center

A clinical trial to evaluate treatments using Oral Azacitidine for patients with Leukemia, Myeloid, Acute or Myelodysplastic Syndromes

Seattle : Seattle Cancer Care Alliance

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Seattle : University of Washington

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Seattle : Swedish Cancer Institute Updated

A Phase 3 clinical study for patients with AML

Seattle : Virginia Mason Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Seattle : Fred Hutchinson Cancer Research Center

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Seattle : University of Washington

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Seattle : Fred Hutchinson Cancer Research Center

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Seattle : Seattle Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Spokane : Medical Oncology Associates PS

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spokane : US Oncology - Cancer Care Northwest - Mission

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spokane : US Oncology - Cancer Care Northwest - Holland

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spokane : US Oncology - Cancer Care Northwest - Sherman

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tacoma : Northwest Medical Specialties Rainier Physicians, PC

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Tacoma : Multicare Research Institute

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 136th St.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 134th St

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Vancouver : Northwest Cancer Specialists, PC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Walla Walla : Providence St. Mary Regional Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Yakima : US Oncology - Yakima Valley Memorial Hospital/North Star Lodge (Boyd)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Yakima :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Yakima : Yakima Valley Memorial Hospital North Star Lodge

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Yakima : Yakima Valley Memorial Hospital/North Star Lodge

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

BMTCTN1101: A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (haplo-BM) for Patients with Hematologic Malignancies

Morgantown : West Virginia University - Clinical Trials Research Unit

CASE 1908: A Phase I/II Study of Midostaruin(PKC412) and 5-Azaacitidine for Elderly Patients with Acute Myelogenous Leukemia

Wisconsin

Green Bay : St. Vincent Hospital

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Green Bay : St. Vincent Hospital/Green Bay Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Green Bay : Green Bay Oncology

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Madison : University of Wisconsin Hospital and Clinics

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Milwaukee : Medical College of Wisconsin

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Milwaukee : Midwest Children's Cancer Center

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Milwaukee : Froedtert Hospital and the Medical College of Wisconsin

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Milwaukee : Aurora Research Institute Aurora Health Care

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Milwaukee : Medical College of Wisconsin Cancer Center

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Milwaukee : Medical College of Wisconsin

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Waukesha : Waukesha Memorial Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Argentina

Caba : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Australia

Adelaide :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Adelaide : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Adelaide : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Adelaide : Royal Adelaide Hospital Updated

A Phase 3 clinical study for patients with AML

Australia : Westmead Hospital Updated

A Phase 3 clinical study for patients with AML

Box Hill : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Brisbane : Site Reference ID/Investigator# 98837

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Brisbane : The Princess Alexandra Hospital Updated

A Phase 3 clinical study for patients with AML

Brisbane : Royal Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Canberra : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Clayton : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Coburg : Site Reference ID/Investigator# 98835

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Douglas : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

East Melbourne : GSK Investigational Site

A clinical trial seeking patients for a Cancer treatment research study

East Melbourne : Site Reference ID/Investigator# 91795

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Fitzroy : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Kingswood : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Kogarah : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Kogarah : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Liverpool : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Melbourne : Box Hill Hospital, Eastern Health

A Phase 2 clinical study for patients with Acute Myeloid Leukemia

Melbourne : Alfred Hospital Updated

A Phase 3 clinical study for patients with AML

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Melbourne : Royal Children's Hospital, Melbourne

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Nedlands : Novartis Investigative Site

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Parkville : Site Reference ID/Investigator# 91794

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Parkville : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Parkville : Royal Melbourne Hospital Updated

A Phase 3 clinical study for patients with AML

Parkville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Prahran :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Queensland :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Randwick : The Sydney Children's Hospital, Centre for Children's Cancer and Blood Disorders

Patients are needed to participate in a clinical research study to evaluate Leukemia

St. Leonards : Site Reference ID/Investigator# 98836

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Sydney : Sydney Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Westmead :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Westmead : The Children's Hospital at Westmead, Department of Oncology

Patients are needed to participate in a clinical research study to evaluate Leukemia

Westmead, NSW : Children's Hospital at Westmead

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Woodend : Canberra Hospital and Health Services Updated

A Phase 3 clinical study for patients with AML

Woodville : The Queen Elizabeth Hospital Updated

A Phase 3 clinical study for patients with AML

Austria

Dornbirn : Krankenhaus Dornbirn, Abt. für Kinder- und Jugendheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Graz : Univ.-Kinderklinik Graz, Abt. Pädiatrische Hämato-Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Innsbruck : Department f. Kinder- u. Jugendheilkunde, Universitätsklinik f. Pädiatrie II

Patients are needed to participate in a clinical research study to evaluate Leukemia

Klagenfurt : A.oe. Landeskrankenhaus Klagenfurt, Abt. für Kinder- und Jugendheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Leoben : A.oe. Landeskrankenhaus Leoben, Abt. für Kinder und Jugendliche

Patients are needed to participate in a clinical research study to evaluate Leukemia

Linz : Landes-Kinderklinik Linz, Haematologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Salzburg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Salzburg : St. Johanns Spital / Landeskrankenhaus, Salzburg, Kinderspital Abt. Kinder u. Jugendheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Vienna : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Vienna : St. Anna Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Wien : 1230.27.43001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Wien : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Wien : St. Anna Kinderspital, Zentrum für Kinder- und Jugendheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Belgium

Antwerp : ZNA Stuivenberg

Patients are needed to participate in a clinical research study of MEN1112 to evaluate Recurrent Adult Acute Myeloid Leukemia or Acute Myeloid Leukemia, in Relapse

Antwerpen : Ziekenhuis Netwerk Antwerpen

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Belgium : Algemeen Ziekenhuis Sint-Jen Updated

A Phase 3 clinical study for patients with AML

Brugge : AZ St Jan AV

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Brussel : UCL St Luc Updated

A Phase 3 clinical study for patients with AML

Brussels : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Bruxelles : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Gent : 1230.27.32001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Gent : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Gent : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Gent : University Hospital of Gent (UZ Gent)

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Godinne : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Leuven : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Leuven : Department of Haemotology at UZ Leuven (7th Floor)

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Leuven : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Leuven : University Hospitals Leuven

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Liège : Hematology Department of CHU de Liège

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Verviers : Hematology Department CHPLT Verviers

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Brazil

Barretos : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Rio de Janeiro : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

São Paulo : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Canada

Barrie : Royal Victoria Regional Health Centre

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Barrie : Royal Victoria Regional Health Centre

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Calgary : Tom Baker Cancer Centre

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Edmonton : University of Alberta Hospital Updated

A Phase 3 clinical study for patients with AML

Moncton : Horizon Health Network - The Moncton Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Montreal : Site Reference ID/Investigator# 99476

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Montreal : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Montreal : Sir Mortimer B. Davis-Jewish General Hospital

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Montreal : Sainte Justine University Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Oshawa : RSM Durham Regional Cancer Centre - Lakeridge Health

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Quebec : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Québec : CHU de Québec - Hôpital de l'Enfant-Jésus

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Saskatoon : Saskatoon Cancer Centre

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Toronto : Sunnybrook Odette Cancer Center

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Toronto : The Hospital for Sick Kids

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Toronto : Princess Margaret Hospital

A clinical trial to evaluate treatments using Aprepitant for patients with Acute Myeloid Leukemia

Toronto : University Health Network, Princess Margaret Hospital

A clinical trial to evaluate treatments using Revlimid for patients with Acute Myeloid Leukemia

Toronto : Princess Margaret Cancer Centre

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Toronto : Hospital for Sick Kids

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Vancouver : Vancouver General Hospital Updated

A Phase 3 clinical study for patients with AML

Vancouver : British Columbia Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

China

Beijing : Beijing Clinical Service Center

Patients are needed to participate in a clinical research study evaluating Bortezomib, Liposome doxorubicin and Dexamethasone for the treatment of Plasma Cell Leukemia or Multiple Myeloma

Tianjin : Hospital of Blood Diseases, Chinese Academy of Medical Sciences

A clinical trial to evaluate treatments using Vincristine Sulfate Liposome and Vincristine Sulfate for patients with Adult Acute Lymphoblastic Leukemia

Tianjin : Hematologic hospital of Chinese academy of medical sciences

Patients are needed to participate in a clinical research study of Bendamustine Hydrochloride Injection and Chlorambucil to evaluate Chronic Lymphocytic Leukemia, Leukemia or Neoplasms

Czech Republic

Brno : Fakultní nemocnice Brno

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Brno : University Hospital Brno, Department of Pediatric Oncology

Patients are needed to participate in a clinical research study to evaluate Leukemia

České Budějovice : Regional Hospital České Budějovice, Department of Pediatrics

Patients are needed to participate in a clinical research study to evaluate Leukemia

Hradec Králové : Fakultní nemocnice Hradec Králové

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Hradec Králové : University Hospital Hradec Králové, Department of Pediatrics

Patients are needed to participate in a clinical research study to evaluate Leukemia

Olomouc : Fakultní nemocnice Olomouc

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Olomouc : University Hospital Olomouc, Department of Pediatrics

Patients are needed to participate in a clinical research study to evaluate Leukemia

Ostrava-Poruba : Teaching Hospital Ostrava-Poruba, Department of Pediatrics

Patients are needed to participate in a clinical research study to evaluate Leukemia

Plzeň : University Hospital Plzeň, Department of Pediatrics

Patients are needed to participate in a clinical research study to evaluate Leukemia

Prague : 1230.27.42001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Prague : Všeobecná fakultní nemocnice v Praze

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Prague : Ustav hematologie a krevní transfúse (UHKT)

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Praha 2 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Praha 5 : University Hospital Motol, Department of Pediatric Hematology and Oncology

Patients are needed to participate in a clinical research study to evaluate Leukemia

Ústí nad Labem : Masaryk´s Hospital Ústí nad Labem, Department of Pediatrics

Patients are needed to participate in a clinical research study to evaluate Leukemia

Denmark

Aahus : Aarhus University Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Aalborg : Aalborg University Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Copenhagen : Department of Haematology, National University Hospital, Rigshospitalet

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Copenhagen : Copenhagen University Hospital Rigshospital

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia

Copenhagen : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Herlev : Herlev Hospital

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Herlev : Herlev Hospital

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia

Odense : Odense University Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Egypt

Cairo : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Finland

HUS : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

France

Amiens : Groupe Hospitalier Sud

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Angers : Chu D'Angers

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Angers Cedex 1 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Besançon : Hôpital Jean Minjoz

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Bobigny : Centre Hospitalier Universitaire Hôpital Avicenne

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Bobigny Cedex : Site Reference ID/Investigator# 98840

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Bordeaux : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Bordeaux : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Bordeaux : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Bordeaux : Institut Bergonié

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Caen : CHU de Caen Updated

A Phase 3 clinical study for patients with AML

Clermont-ferrand : CHU Estaing

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Clermont-Ferrand : CHU de Clermont-Ferrand

A Phase 2 clinical study for patients with Leukemia, Lymphoid or Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Créteil : Hôpital Henri Mondor

A clinical research study of mPEG-r-crisantaspase for the treatment of Hematologic Malignancies

Grenoble : Hôpital Michallon

A Phase 2 clinical study for patients with Leukemia, Lymphoid or Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Le Chesnay : Centre Hospitalier de Versailles Updated

A Phase 3 clinical study for patients with AML

Le Chesnay : Hôpital Mignot - Service d'Hématologie et d'Oncologie

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Lille : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Lille :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Lille : CHRU de Lille -Hôpital Claude Huriez Service des Maladies du Sang

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Lille : CHU Lille

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Lille cedex : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Lyon : Xavier THOMAS

A clinical research study of Plerixafor granulocyte-colony stimulating factor for the treatment of Acute Myeloid Leukemia

Lyon : 1230.27.33005 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Lyon : Hôpital Edouard Herriot

A Phase 2 clinical study for patients with Leukemia, Lymphoid or Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Lyon Cedex 08 : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Marseille : Institut Paoli Calmettes Updated

A Phase 3 clinical study for patients with AML

Marseille : Hopital de la Conception Updated

A Phase 3 clinical study for patients with AML

Montpellier : Hôpital Saint Eloi

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Montpellier :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Nanes : CHU De Nantes

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Nantes : Hôpitaux du CHU de Nantes

A clinical research study of mPEG-r-crisantaspase for the treatment of Hematologic Malignancies

Nantes : Hôtel Dieu - CHU de NANTES

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Nantes : 1230.27.33003 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Nantes : Centre Hospitalier Universitaire Nantes Updated

A Phase 3 clinical study for patients with AML

Nantes 1 : "CHU Hôtel-Dieu Service Hématologie

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Nimes : CHRU de Nîmes

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Nîmes : Centre Hospitalier Universitaire de Nîmes

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Paris : 1230.27.33004 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Paris : 1230.27.33002 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Paris : Hoiptal St Louis T4

A clinical trial seeking patients for a research study for the treatment of MDS

Paris : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Paris : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Paris : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Paris : Hôpital Saint Louis Updated

A Phase 3 clinical study for patients with AML

Paris : Hopital Saint-Antoine Updated

A Phase 3 clinical study for patients with AML

Paris : Hôpital St. Louis

Patients are needed to participate in a clinical research study of oral rigosertib and Azacitidine to evaluate Myelodysplastic Syndrome, Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

Paris : Children Armand Trousseau Hospital

Patients are needed to participate in a clinical research study of proleukin to evaluate Leukemia

Paris, Cedex 13 : Site Reference ID/Investigator# 98842

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Pessac : Hôpital Haut-Lévèque

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Pessac : Hopital Haut Leveque Centre Francois Magendie Updated

A Phase 3 clinical study for patients with AML

Pierre Benite : Centre hospitalier Lyon Sud

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Pierre Benite : Site Reference ID/Investigator# 98839

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Pierre Benite :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Pierre Bénite : Centre Hospitalier Lyon Sud - Service Hématologie - IG

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Pierre-Bénite : Hospices Civils de Lyon

A clinical research study of mPEG-r-crisantaspase for the treatment of Hematologic Malignancies

Poitiers : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Poitiers : INSERM CIC 1402 - CHU de Poitiers

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Pringy : Hopital Région d'Annecy

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Rouen : Centre Henri Becquerel

A clinical research study of mPEG-r-crisantaspase for the treatment of Hematologic Malignancies

Rouen : Site Reference ID/Investigator# 98838

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Rouen :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Rouen : Centre Henri-Becquerel Updated

A Phase 3 clinical study for patients with AML

Rouen : Centre de Recherche en Cancerologie de Marseille- Institute Paoli Calmettes

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Rouen Cedex 1 : Centre Henri Becquerel

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Saint Priest en Jarez Cedex : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Saint-priest-en-jarez : Institut de Cancérologie de la Loire

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

St Priest en Jarez : Institut de Cancerologie de la Loire

A Phase 2 clinical study for patients with Leukemia, Lymphoid or Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Strasbourg : Hopital de Hautepierre

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Strasbourg : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Strasbourg : Oncologie Centre de Radiothérapie

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Toulouse : Institut Claudius Regaud

A clinical research study of mPEG-r-crisantaspase for the treatment of Hematologic Malignancies

Toulouse : Centre Hospitalier Universitaire Purpan Updated

A Phase 3 clinical study for patients with AML

Toulouse : CHU Purpan

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Toulouse cedex 9 : IUCT - Oncopôle

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

TOURS Cedex : Groupe Ouest Est d'etude des Leucemies et Autres Maladies du Sang

Patients are needed to participate in a clinical research study evaluating Rituximab for the treatment of Leukemia

Vandoeuvre Les Nancy : Hopital de Brabois

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Villejuif : 1230.27.33001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Villejuif : Department of Medical Oncology-Institut Gustave Roussy

A clinical trial to evaluate treatments using CC-115 for patients

Germany

Aachen : Uniklinikum Aachen, AöR, Med. Klin. IV Onkologie, Hämatologie und Stammzelltransplantation

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Aachen : Kinderklinik der med. Fakultät der RWTH, Bereich Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Augsburg : Childrens's Hospital, Pediatric Oncology and Hematology

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Augsburg : I. Klinik für Kinder u. Jugendliche, Klinikum Augsburg, Hämatologie/ Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Bayreuth : Klinikum Bayreuth, Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Berlin : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Berlin : Charité Universitätsmedizin Berlin Updated

A Phase 3 clinical study for patients with AML

Berlin : Charité Campus Virchow Klinikum Updated

A Phase 3 clinical study for patients with AML

Berlin : Charité, CVK, Med. Klinik m. S Hämatologie und Onkologie

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Berlin : Charitè; Campus Benjamin Franklin

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Berlin : Klinikum Berlin-Buch II. Kinderklinik, Bereich Onkologie/Allg. Pädiatrie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Berlin : Kinderklinik der Charité, Campus Virchow Klinikum (CVK), Abt.: Kinderhämatologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Bonn : Universitätsklinikum Bonn, Med. Klinik und Poliklinik III

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Braunschweig : Klinikum Braunschweig Updated

A Phase 3 clinical study for patients with AML

Braunschweig : Städtisches Krankenhaus, Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Bremen : Ev. Diakonie-Krankenhaus Gemeinnutzige GMBH Medizinische Klinik 2

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Bremen : Prof. Hess Childrens's Hospital, Pediatric Oncology and Hematology

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Chemnitz : Klinikum Chemnitz gGmbH, Klinik für Kinder- und Jugendmedizin, Hämatologie / Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Cologne : German CLL Study Group

A clinical trial to evaluate treatments using lenalidomide and Placebo for patients with Chronic Lymphocytic Leukemia

Cologne : University Hospital Cologne

A clinical trial to evaluate treatments using lenalidomide and Placebo for patients with Chronic Lymphocytic Leukemia

Cottbus : Carl-Thiem-Klinikum, Kinderklinik, Abt. Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Darmstadt : Please contact the Merck KGaA Communication Center

A clinical research study of MSC2490484A for the treatment of Advanced Solid Tumors or Chronic Lymphocytic Leukemia

Datteln : Vestische Kinder- u. Jugendklinik, Universitätsklinik Witten/Herdecke

Patients are needed to participate in a clinical research study to evaluate Leukemia

Detmold : Klinikum Lippe-Detmold, Kinder- und Jugendmedizin

Patients are needed to participate in a clinical research study to evaluate Leukemia

Dortmund : Klinikum Dortmund, Klinik f. Kinder- und Jugendmedizin

Patients are needed to participate in a clinical research study to evaluate Leukemia

Dresden : UNIVERSITÄTSKLINIKUM TU DRESDEN Medizinische Klinik und Poliklinik I,

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Dresden :

A clinical research study of BAY1143572 for the treatment of Leukemia, Acute Leukemia

Dresden : Site Reference ID/Investigator# 113256

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Dresden : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Dresden : Universitatsklinikum Dresden Updated

A Phase 3 clinical study for patients with AML

Dresden : Universitätsklinikum Carl Gustav Garus

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Dresden : Uni.Klinik Carl Gustav Carus, Klinik f. Kinderheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Duesseldorf : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Düsseldorf : University Hospital Düsseldorf

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Düsseldorf : Universitätskinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Erfurt : Helios Klinikum Erfurt GmbH, Klinik für Kinderheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Erlangen : Universitätsklinikum Erlangen, Kinder- und Jugendmedizin, Abt. für Onkologie/ Hämatologie/Immunologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Essen : University Childrens's Hospital, Pediatric Oncology and Hematology

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Essen : 1230.27.49005 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Essen : Universitätsklinikum Essen, Klinik für Hämatologie

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Essen : Universitätsklinikum Essen, Kinderklinik, Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Frankfurt :

A clinical research study of BAY1143572 for the treatment of Leukemia, Acute Leukemia

Frankfurt : 1230.27.49004 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Frankfurt : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Frankfurt : Klinikum der Johann Wolfgang-Goethe-Universität Updated

A Phase 3 clinical study for patients with AML

Frankfurt : Universitäts-Kinderklinik, Klinik für Kinderheilkunde III, Pädiatrische Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Freiburg : University Children's Hospital, Clinic IV

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Freiburg : Site Reference ID/Investigator# 113276

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Freiburg :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Freiburg : Universitätsklinikum Freiburg, Klinik für Innere Medizin I, Hämatologie, Onkologie und Stammzelltransplantation

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Freiburg : Universitäts-Kinderklinik, Haematologie/ Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Gießen : Klinikum der Justus-Liebig-Universität, Zentrum für Kinderheilkunde, Abt. Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Goettingen : Site Reference ID/Investigator# 113258

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Göttingen : Universitäts-Kinderklinik Päd. I, Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Halle : Universitätsklinikum Halle Updated

A Phase 3 clinical study for patients with AML

Halle : Martin-Luther-Universität Halle-Wittenberg

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Halle : Uniklinikum d. Martin Luther Universität, Halle Wittenberg, Univ.-und Poliklinik für Kinder- und Jugendmedizin

Patients are needed to participate in a clinical research study to evaluate Leukemia

Hamburg : Department of Pediatric Oncology and Hematology University Hospital Eppendorf (UKE)

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Hamburg : Site Reference ID/Investigator# 121075

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Hamburg : University Medical Center Hamburg-Eppendorf

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Hamburg : Universitätsklinikum Hamburg-Eppendorf - Onkologisches Zentrum

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Hannover : University Children's Hospital, Pediatric Oncology and Hematology, MHH

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Hannover : Medizinische Hochschule Hannover

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Hannover : Medizinische Hochschule Hannover, Zentrum Kinderheilkunde u. Jugendmedizin

Patients are needed to participate in a clinical research study to evaluate Leukemia

Hanover : Medizinische Hochschule Hannover Updated

A Phase 3 clinical study for patients with AML

Heidelberg : Clinic for Pediatric Oncology, Hematology, Immunology and Clinical Cooperation Unit Pediatric Oncology

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Heidelberg : Site Reference ID/Investigator# 98845

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Heidelberg : University Hospital Heidelberg

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Heidelberg : Universitäts-Kinderklinik, Päd. Onkologie, Hämatologie, und Immunologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Heilbronn : Klinikum Heilbronn GmbH, Klinik für Kinderheilkunde und Jugendmedizin/Perinatalzentrum

Patients are needed to participate in a clinical research study to evaluate Leukemia

Herdecke : Gemeinschaftskrankenhaus Herdecke, Kinderabteilung

Patients are needed to participate in a clinical research study to evaluate Leukemia

Homburg : Site Reference ID/Investigator# 113259

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Homburg / Saar : Universitätsklinik für, Kinder- und Jugendmedizin, Päd. Hämatologie/ Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Jena : University Childrens's Hospital, Pediatric Oncology and Hematology

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Jena : Universitaetsklinikum Jena

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Jena : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Jena : Universitätsklinikum Jena Updated

A Phase 3 clinical study for patients with AML

Jena : Klinikum, der Friedrich-Schiller-Universität, Klinik für Kinder- und Jugendmedizin

Patients are needed to participate in a clinical research study to evaluate Leukemia

Jena Lobeda-Ost : Universitätsklinikum Jena, Klinik für Innere Medizin II

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Karlsruhe : Städtisches Klinikum Karlsruhe, Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Kassel : Klinikum Kassel, Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Kiel : Site Reference ID/Investigator# 113235

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Kiel :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Kiel : UKSH Campus Kiel

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Kiel : Klinik für Allgemeine Paediatrie, Univ.-Klinikum Schleswig-Holstein, Campus Kiel

Patients are needed to participate in a clinical research study to evaluate Leukemia

Koblenz : Städtisches Krankenhaus Kemperhof, Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Koeln : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Koeln : Site Reference ID/Investigator# 98847

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Koeln : Uniklinik Koln

A clinical trial to evaluate treatments using CC-115 for patients

Koeln :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Köln : University Children's Hospital, Pediatric Oncology and Hematology

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Köln : 1230.27.49002 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Köln : University Hospital Köln

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Köln : Kliniken der Stadt Köln GmbH, Kinderkrankenhaus Riehl

Patients are needed to participate in a clinical research study to evaluate Leukemia

Köln : Med. Einrichtungen der Universität zu Köln, Klinik für Allg. Kinderheilkunde, Onkologisch-hämatologische Station

Patients are needed to participate in a clinical research study to evaluate Leukemia

Leipzig : Abteilung Hämatologie, internistische Onkologie und Hämostaseologie

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Leipzig : Universitätsklinikum Leipzig Updated

A Phase 3 clinical study for patients with AML

Leipzig : University Hospital Leipzig

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Leipzig : Universitätsklinikum Leipzig, Abteilung für Internistische Onkologie und Hämatologie

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Leipzig : University of Leipzig

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Leipzig : Department für Frauen- und Kindermedizin, Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Lübeck : Universität zu Lübeck, Klinik für Kinder- u. Jugendmedizin, Abt. Hämatologie/ Onkologie/Immunologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Magdeburg : Schwerpunktpraxis für Hämatologie und Onkologie

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Magdeburg : Universitätsklinikum Magdeburg, Klinik für Päd. Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Mainz : Site Reference ID/Investigator# 113236

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Mainz : University Mainz Updated

A Phase 3 clinical study for patients with AML

Mannheim : Universitätsmedizin Mannheim Updated

A Phase 3 clinical study for patients with AML

Mannheim : III. Med. Klinik, Klin. Fakultät Mannheim

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Mannheim : Klinikum Mannheim gGmbH, Kinderklinik, Abt. Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Marburg : Universitätsklinikum Giessen und Marburg GmbH Updated

A Phase 3 clinical study for patients with AML

Minden : Johannes Wesling Klinikum Minden

Patients are needed to participate in a clinical research study to evaluate Leukemia

Munchen : LMU München Klinikum Großhadern Updated

A Phase 3 clinical study for patients with AML

München :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

München : Städt. Krankenhaus München GmbH, Krankenhaus München-Schwabingen, Kinderklinik d. TU

Patients are needed to participate in a clinical research study to evaluate Leukemia

Munich : Site Reference ID/Investigator# 113237

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Munich : Site Reference ID/Investigator# 113275

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Münster : UNIVERSITY HOSPITAL OF MÜNSTER Medizinische Klinik und Poliklinik A, Universitätsklinikum Münster

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Münster : Department of Pediatric Oncology and Hematology University Children's Hospital

A clinical research study of zolinza/vorinostat for the treatment of Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Münster : Universitätsklinikum Münster

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Münster : Unviersity Hospital of Münster (UKM)

Patients are needed to participate in a clinical research study evaluating Pazopanib for the treatment of Acute Myeloid Leukemia (AML)

Münster : Universitäts-Kinderklinik, Päd. Hämatologie und Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Nürnberg : Cnopf'sche Kinderklinik, Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Oldenburg : Klinikum Oldenburg gGmbH, Zentrum für Kinder- u. Jugendmedizin, (Elisabeth Kinderkrankenhaus)

Patients are needed to participate in a clinical research study to evaluate Leukemia

Rostock : Universitäts-Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Sankt Augustin : Asklepios-Klinik, Sankt Augustin GmbH

Patients are needed to participate in a clinical research study to evaluate Leukemia

Schwerin : HELIOS Kliniken Schwerin, Klinik f. Kinder-u. Jugendmedizin

Patients are needed to participate in a clinical research study to evaluate Leukemia

Stuttgart : Olga-Hospital, Kinderklinik, Pädiatrisches Zentrum, Abt. Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Trier : Krankenanstalt Trier, Mutterhaus der Borromaeerinnen, Pädiatrische Abteilung

Patients are needed to participate in a clinical research study to evaluate Leukemia

Tubingen : Universitat Tubingen

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Tübingen : University Hospital Tübingen

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Tübingen : Universitäts-Kinderklinik, Abt. Kinderheilkunde II, Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

ULM : Universitätsklinikum Ulm

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Ulm : Site Reference ID/Investigator# 92533

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Ulm :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Ulm : Medizinische Klinik und Poliklinik

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Ulm : Universitätsklinikum Ulm

Patients are needed to participate in a clinical research study of EPZ-5676

Ulm : Universitäts-Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Wolfsburg : Stadtkrankenhaus, Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Wuerzburg : Universitatsklinikum Wuerzburg

A clinical trial to evaluate treatments using CC-115 for patients

Würzburg : Universitäts-Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Greece

Athens : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Patra : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Thessaloniki : George Papanicolaou Hospital

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Hungary

Budapest : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Budapest : Semmelweis Egyetem I. Belgyógyászat

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Debrecen : Debreceni Egyetem Klinikai Központ Belgyógyászati Inézet Hematológiai Tanszék

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Debrecen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Gyor : Petz Aladár Megyei Oktatókórház, II. Belgyógyászati Osztály és Haematológiai Részleg

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Kaposvár : Somogy Megyei Kaposi Mór Oktató Kórház

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Szeged : Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ II.sz. Belgyógyászati Klinika

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Indonesia

Jakarta : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Israel

Afula : HaEmek Medical Center

Patients are needed to participate in a clinical research study to evaluate Leukemia

Beer-Sheva : Soroka Medical Center

Patients are needed to participate in a clinical research study to evaluate Leukemia

Haifa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Haifa : Bnai-Zion Medical Center

Patients are needed to participate in a clinical research study to evaluate Leukemia

Haifa : Rambam Medical Center

Patients are needed to participate in a clinical research study to evaluate Leukemia

Jerusalem : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Jerusalem : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Jerusalem : Hadassah University Medical Center

Patients are needed to participate in a clinical research study to evaluate Leukemia

Kfar Saba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Petach Tikva : Schneider Children Medical Center of Israel

Patients are needed to participate in a clinical research study to evaluate Leukemia

Tel Aviv : Tel Aviv Sourasky Medical Centre

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Tel Hashomer : Chaim Sheba Medical Center

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Tel-Aviv : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Tel-Aviv : Dana children hospital

Patients are needed to participate in a clinical research study to evaluate Leukemia

Tel-Hashomer : Sheba Medical Center

Patients are needed to participate in a clinical research study to evaluate Leukemia

Italy

Ancona : Centro Regionale Oncoematologia Pediatrica Ospedale dei Bambini "G. Salesi" Clinica Pediatrica

Patients are needed to participate in a clinical research study to evaluate Leukemia

Bari : AOU Policlinico Consorziale di Bari Updated

A Phase 3 clinical study for patients with AML

Bari : Dipartimento Biomedicina Età Evolutiva U.O Pediatrica I Policlinico

Patients are needed to participate in a clinical research study to evaluate Leukemia

Belluno : U.O.C. Pediatria e Patologia Neonatale Ospedale San Martino

Patients are needed to participate in a clinical research study to evaluate Leukemia

Bergamo : USC Ematologia

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Bergamo : U.O. Pediatrica - OO.RR Bergamo

Patients are needed to participate in a clinical research study to evaluate Leukemia

Bologna : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Bologna : A.O.U. Policlinico S.Orsola-Malpighi, U.O. Ematologia

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Bologna : Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Università degli Studi di Bologna

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Bologna : Istituto di Ematologia "L e A Seragnoli" Policlinico S.Orsola-Malpighi

A clinical trial to evaluate treatments using Tipifarnib plus Bortezomib for patients with Acute Myeloid Leukemia

Bologna : Università di Bologna Updated

A Phase 3 clinical study for patients with AML

Bologna : Policlinico S.Orsola -Malpighi, Istituto di Ematologia "L.&A.Seràgnoli"

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Bologna : Oncologia ed Ematologia "Lalla Seràgnoli" Clinica Pediatrica Policlinico Sant'Orsola Malpighi

Patients are needed to participate in a clinical research study to evaluate Leukemia

Bologna : Istituto Ortopedico Rizzoli Sez. di chemioterapia dei tumori dell'apparato locomotore

Patients are needed to participate in a clinical research study to evaluate Leukemia

Bolzano : Pediatria Ospedale Regionale

Patients are needed to participate in a clinical research study to evaluate Leukemia

Brescia : Clinica Pediatrica Oncoematologia pediatrica e TMO Ospedale dei Bambini

Patients are needed to participate in a clinical research study to evaluate Leukemia

Cagliari : ASL 8 Cagliari - P.O. Armando Businco

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Cagliari : Istituto di Clinica Pediatrica Ospedale Regionale per le Microcitemie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Catania : A.O.U. Policlinico V. Emanuele - Ospedale Ferrarotto

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Catania : Divisione Ematologia - Oncologia Pediatrica Clinica Pediatrica

Patients are needed to participate in a clinical research study to evaluate Leukemia

Catanzaro : Unità Operativa di Ematologia ed Oncologia Pediatrica Az. Osp. "Pugliese-Ciaccio"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Cosenza : Unità Operativa Pediatria Azienda Ospedaliera Annuziata

Patients are needed to participate in a clinical research study to evaluate Leukemia

Ferrara : Arcispedale S Anna Updated

A Phase 3 clinical study for patients with AML

Ferrara : Dipartimento di Medicina Clinica e Sperimentale Sezione di Pediatria Università di Ferrara

Patients are needed to participate in a clinical research study to evaluate Leukemia

Firenze : AOU Careggi Updated

A Phase 3 clinical study for patients with AML

Firenze : Ospedale di Careggi

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Firenze : Azienda Ospedaliero Universitaria Careggi

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Genova : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Genova : Dipartimento di Medicina Interna - Università di Genova

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Genova : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Genova : IRCCS Azienda Ospedaliera Universitaria San Martino Updated

A Phase 3 clinical study for patients with AML

Genova : Ematologia 1

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Genova Quarto : Dipartimento di Ematologia e Oncologia Pediatrica Instituto " G. Gaslini"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Italy : Unità Operativa di Ematologia e Unità Operativa CTMO Updated

A Phase 3 clinical study for patients with AML

Lecce : Ospedale "Vito Fazzi" U.O. di Pediatria

Patients are needed to participate in a clinical research study to evaluate Leukemia

Mestre : U.O. di Ematologia

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Milan : Ospedale San Raffaele Updated

A Phase 3 clinical study for patients with AML

Milan : Fondazione San Raffaele

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Milano : Ospedale Maggiore di Milano

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Milano : Istituto Scientifico San Raffaele

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Milano : Divisione di Oncologia Pediatrica Ist. Nazionale Studio e Cura Tumori

Patients are needed to participate in a clinical research study to evaluate Leukemia

Milano : Divisione Pediatria "Mariani" Ospedale "Niguarda Ca' Granda"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Milano : Clinica Pediatrica II De Marchi

Patients are needed to participate in a clinical research study to evaluate Leukemia

Milano : Unità di Ricerca Clinica Pediatrica HSR TIGET - Istituto Scientifico San Raffaele

Patients are needed to participate in a clinical research study to evaluate Leukemia

Modena : Azienda Ospedaliero-Universitaria Policlinico di Modena

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Modena : U.O. di Ematologia, oncologia e trapianto Azienda Policlinico di Modena

Patients are needed to participate in a clinical research study to evaluate Leukemia

Monza : 1230.27.39002 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Monza : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Monza : Unitá di Ricerca Clinica, U.O. Ematologia Adulti

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Monza : Clinica Pediatrica dell'Università Milano - Bicocca A.O. San Gerardo - Fondazione MBBM

Patients are needed to participate in a clinical research study to evaluate Leukemia

Napoli : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Napoli : Dipartimento di Biochimica e Biotecnologie Mediche - Università degli Studi di Napoli "Federico II"

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Napoli : Divisione di Ematologia - Università degli Studi di Napoli "Federico II"

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Napoli : Azienda Ospedaliera Universitaria Federico II Updated

A Phase 3 clinical study for patients with AML

Napoli : Azienda Ospedaliera Universitaria Federico II

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Napoli : Servizio di Oncologia Pediatrica Dipartimento di Pediatria Seconda Università degli Studi di Napoli

Patients are needed to participate in a clinical research study to evaluate Leukemia

Napoli : A.O. "A. Cardarelli", U.O.S. Talassemia pediatrica ed emoglobinopatie pediatriche

Patients are needed to participate in a clinical research study to evaluate Leukemia

Napoli : Dipartimento di Oncologia A.O. Santobono - Pausilipon

Patients are needed to participate in a clinical research study to evaluate Leukemia

Nocera Inferiore - SA : U.O.C. Pediatria - TIN, Ospedale "Umberto Primo" ASL SA - 1

Patients are needed to participate in a clinical research study to evaluate Leukemia

Novara : S.C.D.U. Azienda Ospedaliera "Maggiore della carità"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Orbassano : S.C. Medicina Interna II ed Ematologia - Laboratorio di Medicina Interna e Molecolare - A.O. San Luigi

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Orbassano : Azienda Ospedaliero Universitaria San Luigi Gonzaga Updated

A Phase 3 clinical study for patients with AML

Padova : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Padova : Dipartimento di Pediatria Università di Padova Cattedra Di Oncoematologia Pediatrica

Patients are needed to participate in a clinical research study to evaluate Leukemia

Palermo : Oncoematologia Pediatrica Ospedale dei Bambini G. di Cristina

Patients are needed to participate in a clinical research study to evaluate Leukemia

Parma : U.O. di Pediatria e Oncoematologia Pediatrica Az. Osp. Di Parma Ospedali Riuniti

Patients are needed to participate in a clinical research study to evaluate Leukemia

Pavia : Divisione di Ematologia - IRCCS Policlinico S. Matteo

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Pavia : Oncoematologia Pediatrica IRCCS, Policlinico San Matteo

Patients are needed to participate in a clinical research study to evaluate Leukemia

Perugia : S.C. di Oncoematologia Pediatrica con Trapianto di CSE, Ospedale "S.M. della Misericordia" A.O. Perugia

Patients are needed to participate in a clinical research study to evaluate Leukemia

Pesaro : U.O. Pediatrica Azienda Ospedaliera San Salvatore

Patients are needed to participate in a clinical research study to evaluate Leukemia

Pesaro : Ematologia, Ospedale di Muraglia

Patients are needed to participate in a clinical research study to evaluate Leukemia

Pescara : Dipartimento di Ematologia Ospedale Civile

Patients are needed to participate in a clinical research study to evaluate Leukemia

Pisa : Centro di Oncoematologia Pediatrica e Trapianto Midollo Osseo Azienda Ospedaliero Universitaria Pisana Ospedale S. Chiara

Patients are needed to participate in a clinical research study to evaluate Leukemia

Ravenna : U.O. Ematologia - Dipartimento di Oncologia ed Ematologia, Presidio Ospedaliero di Ravenna

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Reggio Calabria : Divisione Ematologia Ospedali Riuniti

Patients are needed to participate in a clinical research study to evaluate Leukemia

Reggio Emilia : U.O. Ematologia - Arcispedale Santa Maria Nuova

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Rimini : U.O Pediatria Ospedale Infermi Azienda USL Rimini

Patients are needed to participate in a clinical research study to evaluate Leukemia

Roma : 1230.27.39001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Roma : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Roma : Cattedra di Ematologia - Università "Tor Vergata"

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Roma : Cattedra di Ematologia - Università "La Sapienza"

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Roma : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Roma : ASL RM C- Ospedale Sant' Eugenio

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Roma : Divisione Oncologia Pediatrica Università Cattolica di Roma

Patients are needed to participate in a clinical research study to evaluate Leukemia

Roma : Sezione Ematologia Dipart. di biotecnologie Cellulari ed Ematologia Università "La Sapienza"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Roma : Divisione Oncologia Pediatrica Ospedale "Bambin Gesù"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Roma : Ospedale Sant'Eugenio clinica pediatrica Univ. Tor Vergata

Patients are needed to participate in a clinical research study to evaluate Leukemia

Roma : Divisione di Ematologia Pediatrica Ospedale "Bambin Gesù"Istituto di Ricerca Scientifica

Patients are needed to participate in a clinical research study to evaluate Leukemia

Roma : Oncoematologia pediatrica Università "La Sapienza" Roma

Patients are needed to participate in a clinical research study to evaluate Leukemia

Rome : L'UOC di Ematologia del Policlinico Tor Vergata Updated

A Phase 3 clinical study for patients with AML

Rome : Policlinico Universitario Agostino Gemelli Updated

A Phase 3 clinical study for patients with AML

Rome : Bambino Gesù Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

San Giovanni Rotondo : Divisione di Ematologia - Casa Sollievo della Sofferenza

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

San Giovanni Rotondo : U.O. Oncoematologia Pediatrica Ospedale "Casa Sollievo della Sofferenza"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Sassari : Clinica Pediatrica Università

Patients are needed to participate in a clinical research study to evaluate Leukemia

Siena : U.O.C. Ematologia e Trapianti - Policlinico "Le Scotte"

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Siena : Dipartimento di Pediatria Ostetricia e Medicina della Riproduzione Università degli Studi di Siena

Patients are needed to participate in a clinical research study to evaluate Leukemia

Torino : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Torino : Ospedale Infantile Regina Margherita

Patients are needed to participate in a clinical research study to evaluate Leukemia

Trento : U.O. Medicina II Divisione - Ospedale Santa Chiara

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Tricase : Unità Operativa di Pediatria - U.T.I.N. Az.Osp. "Card. G. Panico"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Trieste : U.O. Emato-Oncologia Pediatrica Università degli studi di Trieste Ospedale Infantile Burlo Garofolo

Patients are needed to participate in a clinical research study to evaluate Leukemia

Udine : Clinica Ematologica - Policlinico Universitario

A clinical trial to evaluate treatments using STI571 for patients with Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia (CEL) or Myeloproliferative Disorders

Udine : SOS Oncologia Pediatrica Policlinico Universitario

Patients are needed to participate in a clinical research study to evaluate Leukemia

Varese : Clinica Pediatrica Università degli Studi dell'Insubria di Varese Ospedale "Filippo del Ponte"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Verona : U.O.C Oncoematologia Pediatrica Policlinico "G.B: Rossi"

Patients are needed to participate in a clinical research study to evaluate Leukemia

Vicenza : Ospedale San Bortolo, U.O. di Pediatria e patologia Neonatale

Patients are needed to participate in a clinical research study to evaluate Leukemia

Japan

Bunkyo-ku : Local Institution

A Phase 1 clinical study for patients with Leukemia

Chubu Region :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Chugoku Region :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Fukuoka : Kyushu University Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Fukuoka : National Hospital Organization Kyushu Cancer Center

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Fukuyama : Research Site

A clinical trial to evaluate treatments using SyB L-0501 for patients with Chronic Lymphocytic Leukemia

Hokkaido Region :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Isehara : Research Site

A clinical trial to evaluate treatments using SyB L-0501 for patients with Chronic Lymphocytic Leukemia

Izumo : Shimane University Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Izumo : Research Site

A clinical trial to evaluate treatments using SyB L-0501 for patients with Chronic Lymphocytic Leukemia

Kagoshima : National Hospital Organization Kagoshima Medical Center

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Kagoshima : Imamura Bunin Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Kagoshima : Kagoshima University Medical and Dental Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Kagoshima : Research Site

A clinical trial to evaluate treatments using SyB L-0501 for patients with Chronic Lymphocytic Leukemia

Kanto Region :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Kashiwa : National Cancer Center Hospital East

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Kinki Region :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Kobe-city : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Kumamoto : Kumamoto University Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Kyoto-city : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Kyushu Region :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Minato-ku : Research Site

A clinical trial to evaluate treatments using SyB L-0501 for patients with Chronic Lymphocytic Leukemia

Nagasaki : Nagasaki University Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Nagasaki : The Japanese Red Cross Nagasaki Genbaku Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Nagoya : Nagoya City University Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Nagoya : Research Site

A clinical trial to evaluate treatments using SyB L-0501 for patients with Chronic Lymphocytic Leukemia

Nakagami : Heart Life Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Oita : Oita Prefectual Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Saitama : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Sasebo : Sasebo City General Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Sendai : Tohoku University Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Shikoku Region :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Shinjuku-ku : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Shinjuku-Ku : Local Institution

A Phase 1 clinical study for patients with Leukemia

Shizuoka : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Tohoku Region :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Tokyo : National Cancer Center Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Toon : Ehime University Hospital

A clinical research study of Lenalidomide for the treatment of Adult T-Cell Leukemia-Lymphoma

Tsu-city : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Yokohama-city : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Korea, Republic of

Anyang-si : Hallym University Sacred Heart Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Busan : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Busan : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Busan : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Busan : Dong A university Hospitae

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Daegu :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Daegu : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Daegu : Keimyung University Dongsan Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Daejeon : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Daejeon : Local Institution

Patients are needed to participate in a clinical research study for the treatment of Leukemia, Myelomonocytic, Chronic or Leukemia-Lymphoma

Gyeonggi-do : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Gyeonggi-do : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Gyeonggi-do : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Incheon : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Jeollabuk-do : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Jeonju : Chonbuk National University Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Jeonnam : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Seoul : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Seoul : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Seoul :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Seoul : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Seoul : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Seoul : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Seoul : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Seoul : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Seoul : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Seoul : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Seoul : Seoul St. Mary's Hospital of the Catholic University of Korea

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Seoul : Kangbuk Samsung Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Seoul : Seoul National University Hospital

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Seoul : Asan Medical Center

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Seoul : Samsung Medical Center

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Seoul : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Seoul : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Seoul : Local Institution

Patients are needed to participate in a clinical research study for the treatment of Leukemia, Myelomonocytic, Chronic or Leukemia-Lymphoma

Seoul : Local Institution

Patients are needed to participate in a clinical research study for the treatment of Leukemia, Myelomonocytic, Chronic or Leukemia-Lymphoma

Seoul : Local Institution

Patients are needed to participate in a clinical research study for the treatment of Leukemia, Myelomonocytic, Chronic or Leukemia-Lymphoma

Seoul : Local Institution

Patients are needed to participate in a clinical research study for the treatment of Leukemia, Myelomonocytic, Chronic or Leukemia-Lymphoma

Seoul, Korea : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Ulsan : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Wonju : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Netherlands

Amsterdam : VU University Medical Center

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Amsterdam : AMC, Academisch Medisch Centrum Afdeling Klinische Hematologie

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Amsterdam : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Amsterdam : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Amsterdam : VU University Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Groningen : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Groningen : Universitair Medisch Centrum Groningen Updated

A Phase 3 clinical study for patients with AML

Nijmegen : Radboud University Medical Center Department of Haematology (476)

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Nijmegen : Radboud University Medical Center Updated

A Phase 3 clinical study for patients with AML

Rotterdam : 1230.27.31001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Rotterdam : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Rotterdam : Erasmus Medical Center Updated

A Phase 3 clinical study for patients with AML

Rotterdam : Erasmus University Medical Center

Patients are needed to participate in a clinical research study of EPZ-5676

Rotterdam : Erasmus MC - Sophia

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Norway

Bergen : Haukeland universitetssjukehus

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Bergen : Haukeland University Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Trondheim : St Olav Hospital

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Trondheim : St. Olavs Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Philippines

Batangas : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Manilla : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Poland

Chorzow : Site Reference ID/Investigator# 98850

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Chorzów : SPZOZ Zespól Szpitali Miejskich w Chorzowie, Oddzial Hematologiczny

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Gdansk : Uniwersyteckie Centrum Kliniczne, Klinika Hematologii i Transplantologii

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Katowice : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Krakow : Site Reference ID/Investigator# 98849

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Łódź : Wojewódzki Szpital Specjalistyczny im M. Kopernika, Klinika Hematologii Uniwersytetu Medycznego

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Lublin : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Lublin : Site Reference ID/Investigator# 98848

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Opole : Site Reference ID/Investigator# 102855

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Rzeszow : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Slupsk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Warszawa : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Wroclaw : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Wroclaw : UM im. Piastów Śląskich we Wrocławiu Katedra i Klinika Hematologii Nowotworów Krwi i Transplantacji Szpiku

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Puerto Rico

San Juan : Auxilio Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Russian Federation

Astrakhan' : Alexandro-Mariinskaia Regional Clinical Hospital/13

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Buryatia : Republic Clinical Hospital n.a. N.A. Semashko

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Cherepovets : Vologda Reginal Clinical Hospital #2

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Irkutsk : Irkutsk Regional Clinical Hospital/08

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Kaliningrad : Kaliningrad City Clinical Hospital

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Kaluga : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Khabarovsk : Regional Clinical Hospital#1/04

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Khanty-Mansiysk : District Cancer Center od Khanty -Mansiysk

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Moscow : Central Clinical Hospital of Department of Presidential Affairs

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Moscow : National Medical Surgical Center n.a.N.I.Pirogov/15

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Moscow : Сentral Clinical Hospital n.a.N.A.Semashko/20

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Moscow : Haematology Centre at Main Military Clinical Hospital n.a. N.N. Burdenko

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Moscow : RONC n.a.N.N.Blokhin/21

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Moscow : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Moscow : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Moscow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Moskow : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Murmansk : Murmansk Regional Clinical Hospital n.a.P.A.Bayandin/31

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Nizhniy Novgorod : Nizhniy Novgorod Regional Clinical Hospital n.a.N.A.Semashko/14

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Nizhniy Novgorod : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Novosibirsk : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Obninsk : Medical Radiology Scientific Center/23

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Orenburg : Orenburg State Medical Academy/011

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Penza : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Petrozavodsk : Karelia Republican Сlinical Hospital n.a.V.A.Baranov/32

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Pskov : Pskov Regional Clinical Hospital

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Rostov-on-Don : Rostov Scientific Research Oncology Institution/03

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Rostov-on-Don : Road clinical hospital on Rostov-Main station OAO RZhD/02

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Saint-Petersburg : Military-Medical Academy n.a. Kirova

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Sankt-Peterburg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Smolensk : Road Clinical Hospital on Smolensk station OAO RZhD/12

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

St. Petersburg : Federal Center of Heart, Blood and Endocrinology n.a.V.A.Almazov/19

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

St. Petersburg : SPb State I. Pavlov Medical University

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Surgut : Surgut Regional Clinical Hospital

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Syktyvkar : Komi Republican Oncology Dispensary /01

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Tula : Tula Regional Clinical Hospital/07

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Tula : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Tyumen : Tyumen Regional Clinical Hospital#1/27

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Ul'yanovsk : Regional Clinical Hospital/26

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Volgograd : Volgograd Regional Clinical Oncology Dispensary#1/25

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Yekaterinburg : Yekaterinburg City Hospital #7

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Yekaterinburg : Yekaterinburg Regional Clinical Hospital #1

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Singapore

Singapore : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Singapore : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Singapore : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Singapore : Singapore General Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Slovakia

Bratislava : 1230.27.42101 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Bratislava : Univerzitná nemocnica Bratislava-Nemocnica sv. Cyrila a Metóda

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Bratislava : Národný onkologický ústav

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Spain

Alcorcón : Hospital Universitario Fundación Alcorcón

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Almeria : Complejo Hospitalario Torrecárdenas

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Alzira : Hospital Universitario La Ribera

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Badalona : Hospital (Universitari(o)) Germans Trias i Pujol

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Barcelona : Hospital del Mar

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Barcelona : Parc de Salut Mar- Hospital del Mar

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Barcelona : Hospital Universitario Vall d'Hebron

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Barcelona : Hospital de la Santa Creu I Sant Pau

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Barcelona : Hospital Duran Reynals

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Barcelona : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Barcelona : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Barcelona : Hospital Clinic i Provincial de Barcelona

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Barcelona : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Barcelona : Hospital Universitario Vall Hebrón

A clinical trial to evaluate treatments using CC-115 for patients

Barcelona : Hospital Clinic I Provincial de Barcelona Updated

A Phase 3 clinical study for patients with AML

Barcelona : Hospital Universitari Germans Trias i Pujol Updated

A Phase 3 clinical study for patients with AML

Barcelona : Hospital Clínic

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Barcelona : Hospital Vall d'Hebron

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Bilbao : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Cádiz : Hospital Universitario Puerta del Mar

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Córdoba : Hospital Universitario Reina Sofía

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Córdoba : Hospital Universitario Reina Sofía

Activity and Safety of Lenalidomide and Rituximab (LenRtx) as Non-chemotherapy Based Therapy for Patients With Chronic Lymphocytic Leukemia

El Palmar : Hospital Universitario Virgen de la Arrixaca

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Elche : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Getafe : Hospital Universitario Getafe

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Girona : Hospital Universitari de Girona Josep Trueta

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Granada : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Hospital de Antequera : Hospital de Antequera

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Hospitalet de LLobregat : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Ibiza : Hospital Can Misses

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

La Coruna : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

La Laguna : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Las Palmas de Gran Canaria : CHU-Insular

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Las Palmas de Gran Canaria : Hospital Universitario de Gran Canaria Doctor Negrín

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

León : Hospital de León

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Lugo : Hospital Lucus Augusti

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Madrid : Hospital Fundación Jimenez Díaz

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Madrid : Hospital Universitario Infanta Leonor

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Madrid : Hospital Clínico San Carlos

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Madrid : Hospital Universitario Ramon y Cajal

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Madrid : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Madrid : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Madrid : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Madrid : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Madrid : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Madrid : Unidad de Fase I 3º planta Hospital Universitario Madrid Sanchinarro

A clinical trial to evaluate treatments using CC-115 for patients

Madrid : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Madrid : Hospital Universitario La Paz Updated

A Phase 3 clinical study for patients with AML

Madrid : Hospital General Universitario Gregorio Marañon Updated

A Phase 3 clinical study for patients with AML

Madrid : Fundación MD Anderson Internacional

Activity and Safety of Lenalidomide and Rituximab (LenRtx) as Non-chemotherapy Based Therapy for Patients With Chronic Lymphocytic Leukemia

Madrid : Hospital Universitario La Paz

Activity and Safety of Lenalidomide and Rituximab (LenRtx) as Non-chemotherapy Based Therapy for Patients With Chronic Lymphocytic Leukemia

Madrid : Hospital Universitario La Princesa

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Madrid : Hospital Clínico San Carlos

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Madrid : Hospital Universitario Gregorio Marañón

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Madrid : Hospital Ramón y Cajal

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Malaga : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Málaga : Hospital Universitario Virgen de la Victoria

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Mallorca : Hospital Son Espases Updated

A Phase 3 clinical study for patients with AML

Murcia : Hospital General Universitario Santa Lucía

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Ourense : Complejo Universitario Hospitalario de Ourense

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Oviedo : Hospital Universitario Central de Asturias

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Palma de Mallorca : Hospital Son Llàtzer

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Pamplona : Complejo Hospitalario de Navarra Updated

A Phase 3 clinical study for patients with AML

Pamplona : Hospital de Navarra

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Pontevedra : Complejo Hospitalrio Universitario de Pontevedra

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Salamanca : Hospital Universitario Salamanca

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Salamanca : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Salamanca : Hospital Clínico Universitario de Salamanca Updated

A Phase 3 clinical study for patients with AML

Salamanca : Hospital Clínico de Salamanca

Activity and Safety of Lenalidomide and Rituximab (LenRtx) as Non-chemotherapy Based Therapy for Patients With Chronic Lymphocytic Leukemia

Salamanca : Hospital Universitario de Salamanca

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

San Sebastian : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

San Sebastian : Hospital de Donosti

A clinical trial to evaluate treatments using CC-115 for patients

San Sebastián : Hospital Universitario Donostia

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Santander : Hospital Universitario Marqués de Valdecilla

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Santander : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Santiago de Compostela : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Santiago De Compostela : Hospital Clínico Universitario

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Sevilla : Hospital de Valme

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Sevilla : Hospital Universitario Virgen Macarena

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Sevilla : Pasillo Onco-Hematología. Sala de Protocolos Hospital Universitario Virgen del Rocío

A clinical trial to evaluate treatments using CC-115 for patients

Sevilla : Hospital Universitario Virgen del Rocio Updated

A Phase 3 clinical study for patients with AML

Sevilla : Hospital Virgen del Rocío

Activity and Safety of Lenalidomide and Rituximab (LenRtx) as Non-chemotherapy Based Therapy for Patients With Chronic Lymphocytic Leukemia

Soria : Hospital Santa Bárbara

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Toledo : Hospital Virgen de la Salud

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Valencia : Hospital Arnau de Vilanova

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Valencia : Hospital Universitario Doctor Peset

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Valencia : Hospital Clínico Universitario Valencia

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Valencia : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Valencia : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Valencia : Hospital La Fe Updated

A Phase 3 clinical study for patients with AML

Valencia : Hospital Clínico Universitario de Valencia

Activity and Safety of Lenalidomide and Rituximab (LenRtx) as Non-chemotherapy Based Therapy for Patients With Chronic Lymphocytic Leukemia

Valencia : Hospital Clínico Universitario de Valencia

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Valladolid : Hospital Universitario Río Hortega

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Valladolid : Hospital Clínico Universitario de Valladolid

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Vitoria : Hospital Universitario Txagorritxu

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Zaragoza : Hospital Clínico Universitario Lozano Blesa

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Zaragoza : Hospital Universitario Miguel Servet

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome or Leukemia, Myelomonocytic, Chronic

Zaragoza : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Zaragoza : Hospital Universitario Miguel Servet

Activity and Safety of Lenalidomide and Rituximab (LenRtx) as Non-chemotherapy Based Therapy for Patients With Chronic Lymphocytic Leukemia

Sweden

Göteborg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Linköping : Linköping University Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Lund : Skåne University Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Örebro : Örebro University Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Stockholm : Karolinska University Hospital Solna

A clinical research study of alemtuzumab, ofatumumab and biopsy for the treatment of Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia or Stage IV Chronic Lymphocytic Leukemia

Stockholm : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Stockholm : Karolinska University Hospital Solna

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Umeå : Norrlands University Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Uppsala : Akademiska Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Switzerland

Aarau : Kinderklinik, Hämatologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Basel : Baseler Kinderspital, Hämatologische Poliklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Bellinzona : Repartio di Pediatria

Patients are needed to participate in a clinical research study to evaluate Leukemia

Luzern : Pädiatrische Klinik, Kinderspital Luzern, Kinderonkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

St. Gallen : Hämatologie/Onkologie, Ostschweizer Kinderspital, FMH Pädiatrie, Hämatologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Zürich : Kinderspital Zürich, Universitäts-Kinderklinik

Patients are needed to participate in a clinical research study to evaluate Leukemia

Taiwan

Kaoshiung :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Taichung :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Tainan :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Taipei :

A clinical trial to evaluate treatments using OCV-501 and Placebo for patients with Acute Myeloid Leukemia

Thailand

Bangkok : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Bangkok : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Bangkok : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Bangkok : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Bangkok : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Bangkok : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Bangkok : Local Institution

A Phase 3 clinical study for patients using Imatinib and Radotinib

Muang : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Turkey

Adana : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Ankara : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Istanbul : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Ukraine

Cherkasy : MI "Cherkasy regional Oncological Dispensary" of Cherkasy Regional Council, Regional Medical and Diagnostic Hematology Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Ivano-Frankivsk : Regional Clinical Hospital in Ivano-Frankivsk, Hematology Department

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Khmelnytskyi : Khmelnytskyi Regional Hospital, Hematology Department

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Kyiv : State Institution "National research center for radiation medicine of NAMS of Ukraine", radiation oncohematology and stem cells

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Kyiv : Kyiv City Clinical Hospital #9, Hematology Department #1, National Medical University named after O.O.Bogomolets,

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Lviv : State Institution "Institute of Blood Pathology and Transfusion Medicine NAMS of Ukraine", Hematology Department

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

United Kingdom

Aberdeen : Aberdeen Royal Infirmary Updated

A Phase 3 clinical study for patients with AML

Basingstoke : Basingstoke and North Hampshire Hospital

Patients are needed to participate in a clinical research study evaluating Ofatumumab, Chlorambucil and Bendamustine for the treatment of Chronic Lymphocytic Leukaemia

Bath : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Bath : Royal United Hospital

Patients are needed to participate in a clinical research study evaluating Ofatumumab, Chlorambucil and Bendamustine for the treatment of Chronic Lymphocytic Leukaemia

Belfast : Belfast City Hospital

Patients are needed to participate in a clinical research study evaluating Ofatumumab, Chlorambucil and Bendamustine for the treatment of Chronic Lymphocytic Leukaemia

Birmingham : Novartis Investigative Site

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Birmingham : Queen Elizabeth Hospital

A clinical trial to evaluate treatments using Azacitidine and Vorinostat for patients with Leukemia, Myeloid, Acute

Birmingham : Heartlands Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Birmingham : Queen Elizabeth Hospital

Patients are needed to participate in a clinical research study evaluating Ofatumumab, Chlorambucil and Bendamustine for the treatment of Chronic Lymphocytic Leukaemia

Bournemouth : Royal Bournemouth Hospital

Patients are needed to participate in a clinical research study evaluating Ofatumumab, Chlorambucil and Bendamustine for the treatment of Chronic Lymphocytic Leukaemia

Bournemouth, Dorset : Site Reference ID/Investigator# 118975

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Bradford : Bradford Royal Infirmary

Patients are needed to participate in a clinical research study evaluating Ofatumumab, Chlorambucil and Bendamustine for the treatment of Chronic Lymphocytic Leukaemia

Bristol : Bristol Haematology and Oncology Centre Updated

A Phase 3 clinical study for patients with AML

Burton-upon-Trent : Queens Hospital

Patients are needed to participate in a clinical research study evaluating Ofatumumab, Chlorambucil and Bendamustine for the treatment of Chronic Lymphocytic Leukaemia

Cambridge : GSK Investigational Site

A clinical trial seeking patients for a Cancer treatment research study

Cambridge : Site Reference ID/Investigator# 119977

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Canterbury : Kent and Canterbury Hospital

Patients are needed to participate in a clinical research study evaluating Ofatumumab, Chlorambucil and Bendamustine for the treatment of Chronic Lymphocytic Leukaemia

Cardiff : University Hospital of Wales

A clinical trial to evaluate treatments using Azacitidine and Vorinostat for patients with Leukemia, Myeloid, Acute

Cardiff : University Hospital of Wales Updated

A Phase 3 clinical study for patients with AML

Cardiff : University Hospital of Wales

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Chester : Countess of Chester Hospital

Patients are needed to participate in a clinical research study evaluating Ofatumumab, Chlorambucil and Bendamustine for the treatment of Chronic Lymphocytic Leukaemia